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Summary: 
This work focuses on mycothiol (MSH), the low molecular weight thiol of M 
tuberculosis, the causative agent of pulmonary TB. It has been proven through numerous 
studies that the enzymes involved in the biosynthesis and related reactions of MSH are 
good drug targets for the design of new antibiotics against M tuberculosis. Unfortunately, 
current screening methods are insufficient and do not allow for the high thought-put 
screening of potential inhibitors against these enzymes. In this work we laid the 
foundation for an improved method to expedite antitubercular drug discovery. 
During this study mycothiol disulfide reductase (Mtr) and the mycothiol biosynthetic 
enzyme MshB were recombinantly expres ed and purified from E. coli. The Mtr enzyme 
was hown to be active in the presence of des-myo-inositol mycothiol disulfide (DI-
M SM), a ubstrate analogue of Mtr. Taken together, these results should greatly 
facilitate the olution of the fir t crystal tructure of this essential M tuberculosis enzyme. 
Such a tructure would be an essential requirement of structure-based drug development 
effort directed at Mtr. Furthermore, we have developed a new ESVMS(TOF)-HPLC 
method for the quantitation of MSII and its pathway intermediates. This new analytical . 
method was employed to detect and quantitate three different pathway analytes from a 
ingle injection of M. megmati cell ly ate. It was al o u ed to determine the fluctuating 
MSH:M M level in M. megmatis cells growing under oxidative stress conditions. 
MshB enzyme reaction were al o analyzed u ing this method. 
A series of substrate analogues were also designed and tested again t both the expressed 
enzymes. The frrst of these, DI-MSSM, was used to test the activity of Mtr. Furthermore, 
two sets of substrate analogues of M hB - one of thioglycoside-di accharides and another 
containing a variety of fluorophores - were designed and synthesized with the goal of 
using the e analogues as scaffolds for the development of new inhibitor libraries. Among 
these analogues, one of the fluorogenic substrates showed better activity with MshB than 
its natural substrate. This molecule was also shown to undergo an intramolecular 
rearrangement, after reacting with MshB. This would be the fir t time this type of 
rearrangement is shown to be enzyme mediated. With further development this molecule 
could be u ed in a photometric-based as ay of MshB. 
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Opsomming: 
Die werkstuk fokus op mikotiol (MSH), wat 'n Jae molekulere gew1g tiol van M 
tuberculosis is. Verskeie studies het alreeds bewys dat die ensieme wat betrokke is by die 
biosintese en sellulere funksies van MSH, goeie teikens is vir die ontwikkeling van nuwe 
M tuberculosis antibiotikums. Huidige metodes vir die evalueering van inhibeerders teen 
hierdie ensieme is onvoldoende en laat nie die toets van groot hoeveelhede inhibeerders 
gelyktydig toe nie. In hierdie betrokke werkstuk word die grondslag gele vir die 
onwikkeling van 'n verbeterde metode vir die ontdekking van antituberkurale middels. 
Gedurende die studie is rnikotiol disulfied reduktase (Mtr) en die rnikotiol biosintetiese 
ensiem, MshB, in E. coli uitgedruk en gesuiwer. Dit is die eerste suksesvolle uitdrukking 
van Mtr in E. coli en maak dit moontlik om die eerste kristalstruktuur van hierdie 
es ensiele M tuberculosis ensiem op te los. Die Mtr kristalstruktuur sal 'n belangrike 
hulpmiddel wees vir truktuurgebaseerde ontwikkeling van middele teen Mtr. 
Yerder, i daar ook 'n nuwe ESI/MS(TOF)-HPLC metode ontwikkel vrr die 
kwantifisering van MSll en sy tus engangers in die biosintese pad. Die nuwe analitiese . 
mctodc is gebruik om drie ver killende tus engangers op te spoor en te kwantifi eer. Al 
drie tu sengangers is in 'n enkele in puiting van M smegmatis sel vervloeiing opgespoor. 
Die metode i ook gebruik om die verandering in M H:MSSM verhoudings te ondersoek 
in M. smegmatis elle wat onder oksidatiewe toestande opgegroei is. Ensiemreaksies met 
MshB i ook geanaliscer met die mctode. 
'n Reeks ub traatanaloc i ook ontwikkel en getoet teen Mtr en M hB. Des-myo-ino itol 
mikotiol disulfied (DI-M SM) is gebruik om die aktiwiteit van Mtr te toets. Verder is 
twee groepe ub traatanaloe teen M hB ontwikkel tiogliko idie e-disakkariede en 
f1uoroscrende substrate, met die doe! om as raamwerk te dien vir die ontwikkeling van 
inhibeerders teen MshB. Daar is gcvind <lat een van die fluoroserende substrate beter 
aktiwiteit toon met MshB as die natuurlike substraat. Dit is ook gewys <lat die molekule 
intramolekulere herrang kiking ondergaan na die inwerking van MshB. Hierdie 
ondekking dien ecrste bewys <lat die tipe intramolekulere herrangskiking deur 'n ensiem 
gemedieer kan word. Met verdere onwikkeling kan hierdie molekule gebruik word in die 
fotometriese analiese van MshB ensiemreaksies. 
v 
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"The joy of discovery is certainly the liveliest that the mind of man can feel" 
Claude Bernard (1813 - 1876) 
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Chapter 1 
Introduction 
1.1 Introduction 
Mycobacterium tuberculosis is the causative agent of pulmonary tuberculosis (TB) (J) 
and one third of people worldwide are infected with the dormant form of this bacterium. 
It is only when the bacteria become active - mainly because of a reduction in an 
individual's immunity - that so-called full-blown TB is developed (2). According to the 
World Health Organization (WHO) an estimated 8.8 million new TB cases were 
reported in 2005 worldwide. During this period a total of 1.6 million people died, of 
which l 95 000 patients were also infected with HN (3). TB is usually treatable with a 
cour e of the first-line anti-TB drugs: pyrazinamide, isoniazid, ethambutol and 
rifampicin. The cour e of these drugs i taken for two months, followed by a four-
month long course of isoniazid and rifampicin. If misapplied, thi drug regime could 
result in the development of multidrug-re istant M tuberculosis (MDR-TB) strains, 
which are defined a trains that have become re istant to at least isoniazid and 
rifampicin ( 4). Almost 4% of new TB cases reported in developing countries are caused 
by the MDR-TB strain (2). 
Extremely drug-resistant M tuberculosis (XDR-TB) trains can develop with the 
continued misuse o[ second-line anti-TB drugs (Amik.acin, Kanamycin and 
apreomycin), which are prescribed for MDR-TB patients. A XDR-TB strain is defined 
as a train of M tuberculosi that i resistant to at least isoniazid and rifampicin, 
fluoroquinolones and any one of the second-line anti-TB drugs. Thus making the 
treatment options for XDR-TB patients dangerously limited (2, 5). The continued 
research and development of new drugs against M tuberculosis is therefore vital in the 
global fight against TB. 
/-
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Chapter I: Introduction 
1.2 Mycothiol: structure and function 
1-D-myo-inosito 1-2-(N-acety 1-L-cysteiny l )-amido-2-deoxy-a-D-glucopyranoside or 
Mycothiol (MSH), is the major low molecular weight thiol present in wide range of 
actinomycetes ( 6). MSH plays an important role in protecting the mycobacterial cell 
similar to the role fulfilled by glutathione in eukaryotic cells,. Some of the main MSH 
functions are: detoxification of cell from alkylating agents, protection of the bacterial 
cell against oxidative stress and cell detoxification from formaldehyde (7-10). In the 
formaldehyde detoxification MSH acts as co-factor for the formaldehyde 
dehydrogenase enzyme in Amycolatopsis methanolica. Also, it was recently 
discovered that MSH serve as a reservoir of biosynthetic precursors and energy-
producing metabolite (J 1). 
The very unique structure of MSH is shown in Figure 1.1. It consists of two sugar 
moieties, N-glucosamine (red) and inositol (black), bound together by an a(l--+1) 
glycosidic bond. Two amide bond also form part of the structure, one connecting the 
cysteine (blue) to the N-gluco amine and another connecting the acetyl group (green) 
to the cysteine. The first cbemo-enzymatic syntbesi of MSH was attempted by 
Bornemann et al., in 1997 (J 2). 
OH HO/~\ HO -
NH 0 
HS OH 
Figure l.l : truclure of mycolhiol 
Because of the unique tructure of MSH, the enzymes involved in its biosynthesis and 
metabolism are all potential targets for new drugs against M tuberculosis and other 
actinomycetes. 
2 
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Chapter 1: Introduction 
1.2.1 Detoxification of alkylating agents and antibiotics 
The key enzyme involved in the MSH-dependent detoxification of alkylating agents 
and antibiotics in M tuberculosis is mycothiol S-conjugate amidase or Mca (Rv1082 
gene product). The enzyme was first discovered in M smegmatis, in a study in which 
monobromobimane (mBBr) was added to M smegmatis cultures in attempts to 
alkylate the free thiol of MSH (7) . It was discovered that derivatised MSH molecules ( 
MSmB) were not exported from the cell. Instead the cysteinyl-glucosamine amide 
bond of the MSmB molecule was hydrolyzed to produce aGLcN-lns and a bimane 
derivatised N-acetylcysteine, AcCysmB (a mercapturic acid). The mercapturic acid is 
transported from the cell either through passive diffusion or a specific export system. 
The general scheme for this detoxification mechanism is depicted in Figure 1.2. The 
aGlcN-Ins moiety is retained in the cell and used in the biosynthesis of MSH (13) . 
&Jjyo 
mBBr ~ 
Figure 1.2: The cellular detoxification mechanism of Mca. 
Mca has a very high specificity for the mycothiol moiety and the enzyme's activity 
dropped considerably when either the acetyl or inositol moieties are removed from the 
MSmB molecule (7). Also the amidase activity was observed with a wide range of 
groups conjugated to the MSH thiol, including an acetophenone moiety which is 
3 
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structurally similar to isoniazid. The MSH S-conjugate of rifamycin S was also shown 
to be a substrate for Mca (13) . It is this feature of Mca that is being exploited in the 
development of inhibitors against this enzyme (14, 15). It was also shown by Rawat et 
al. that M smegmatis mutants deficient of Mca is susceptible for antituberculous 
antibiotics like streptomycin (16). 
1.2.2 Antioxidant activity 
Just like glutathione mycothiol also acts as an antioxidant by reacting with exogenous 
or endogenous reactive intermediates and thereby maintaining an intracellular redox 
homeostasis (17) . During this reaction two equivalents MSH are oxidized to a 
molecule mycothiol disulfide (MSSM). The reverse reaction, catalyzed by mycothiol 
disulfide reducta e or Mtr, reduces the disulfide and returns the original thiol, thereby 
maintaining a constant MSH:MSSM ratio (8) . 
Mtr is encoded for by the gene Rv2855 (mtr). Similar to functionally homologous 
enzyme like glutathione and trypanothione reductase it also depends on bound FAD 
and NADPil for the reduction of the di ulfide bond of MSSM to produce two MSH 
equivalent (18) . The catalytically important redox-active disulfide and a histidine-
glutamate ion pair i al o con erved in these three enzymes. In Mtr these catalytically 
active residues have been identiued as the Ilis444-Glu449 ion pair and Cys39 and 
ys44 (19) . 
4 
Stellenbosch University  https://scholar.sun.ac.za
Chapter 1: Introduction 
NADJ 
FAD 
Cys44- SJ - Jl 
C 39 /) /'.. /-
0 Glu449 
ys -5"' N NH 
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FAD 
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I 
0 
. A. 
/'.. ,,o Glu 449 
+ 
NADP 
FAD 
f 
f 
/ 0 
Cys39- S Cys44-S- -A_ 
Cys39 - S / H,, ,,,;:::.. / O Glu 449 
N· + ·NH ' 
N NW 
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His 444 
~AD FAD 
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'=Z 
His444 
+ Ered 
NADP 
SM 
f f 
Cys44 )s· ? ' o ~ Cys44 - S. • A_ 
Cys39 \ NQH / o Glu4 .... 49-==~Cys39-S) H)N~H/,O Glu449 
M His 444 ! __/ His 444 
M- ' s 
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cheme I.I: Mtr reaction mechanism as propo ed by Patel and Blanchard, 200 I (/ 9). 
The catalytic mechanism of MSH:MSSM redox shuttling wa proposed by Patel and 
Blanchard (Scheme l. I) (19) . Becau e the Mtr crystal structure coordinates have not 
yet been determined, the author relied on pH dependent kinetic tudies, the primary 
sequence and the functional homology between Davoprotein disulfide reductases to 
deduce the propo ed mechanism. They proposed that after the binding of NADPH and 
subsequent hydride tran fer to the bound FAD, electron transfer to the active site 
Jollows. The two electron reduced enzyme is stabilized by the protonated His444, 
which hares a proton with Cys39. After the binding of MSSM, the Cys39 thiolate 
reacts with the MSSM disulfide. A ubstrate-enzyme mixed disulfide is formed with 
the release of the first MSH product. In the final step, an enzyrnic disulfide is formed 
with the release of the econd MSH product. The authors proposed this mechanism 
after numerous pH dependent kinetic studies. 
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The essentiality of Mtr was shown through the application of antisense mtr 
oligonucleotides, which resulted in a 66% reduction of growth in M tuberculosis over 
a seven day period (20) . 
1.2.3 Storage of cysteine and aGlcN-Ins 
Bzymek et al. demonstrated during a study with MSH deficient M smegmatis cells, 
that MSH also serves as a stockpile of available cysteine and aGlcN-Ins. Cells most 
likely make use of this reserve in times of stress (1 I). The key enzyme in the 
catabolism of MSH is Mca which cleaves the MSH molecule to produce GlcN-Ins and 
AcCys. The specific steps of the aGlcN-lns catabolism have not yet been determined, 
but the authors postulate that aGlcN is converted to pyruvate via the glycolytic 
pathway. ft was al o hown that myo-ino itol can erve as the only carbon source for 
M. smegmatis, proving that thi moiety is also catabolized to produce energy and 
bio ynthetic precursors. AcCy is ultimately converted to pyruvate through the 
activity of cysteine desulfhydrase, an activity which was shown to be present in the 
M smegmatis extracts. Before the de ulfuydrase reaction can take place, AcCys has to 
be deacetylated to form Cys, through the activity o[ a deacetylase enzyme. The genes 
encoding for the two enzymes necessary for Ac ys catabolism still needs to be 
identified. 
1.3 Mycothiol biosynthesis 
Mycothiol i produced in a four tep bio ynthetic pathway (Scheme 1.2). MshA 
catalyzes the fir t tep in which N-acetylgluco amine (aGlcNAc) from VDP-
aGlcNAc i transferred to myo-in itol, producing aGlcNAc-In . aGlcNAc-ln i 
deacetylated by MshB to form a lcN-In and thereafter aGlcN-ln is ligated to L-
cysteine. Thi ligation reaction i ATP-dependent and is catalyzed by MshC, forming 
ys-aGlcN-lns. In the final tep of thi pathway M hD tran fer an acetyl group from 
acetyl-CoA to Cys-a.GlcN-lns to produce mycothiol. 
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1.3.l MshA 
MshA belongs to the glycosyltransferase family 4 as shown by the CAZy database 
(21). This family of glycosyltransferases which includes sucrose synthetase, mannosyl 
transferase and aGlcNAc transferase, has two highly conserved motifs present in the 
glycosyl transferase domains (23). These motifs were also found to be conserved in 
MshA. In the M smegmatis mutant of MshA, a glycine in the first conserved motif 
was changed to an asparagine, which resulted in a complete loss of aGlcNAc-Ins 
synthesis. This demonstrated that the first conserved motif is important for the activity 
of MshA. The second conserved motif containes the Glu-X7-Glu signature sequence 
found in all family 4 glycosyltransferases. The homology of MshA with the family 4 
glycosyltran ferases enzymes is proof that the glycosyltransferase is necessary for the 
biosynthe is of aGlcNAc-lns (22). 
The gene encoding MshA, Rv0486 or m hA, wa identified by Newton et al. while 
studying mycothiol deficient M smegmatis mutants (22). Later studies of MshA 
indicated that the enzyme is essential for the growth of M tuberculosis (24). Its 
esscntiality was determined with targeted gene disruption studies. It is also postulated 
that a second MshA enzyme, MshA2, might exi t. These two enzymes, MshA and 
MshA2, together would be re ponsible for the synthesis of aGlcNAc-Ins (Scheme 1.2, 
blue square). Thus, MshA catalyze the transfer of UDP-aGlcNAc to lL-In -1-P, to 
form GlcNAc-(al ,3)-JL-lns-1-P which is subsequently depho phorylated by MshA2 
to produce aGlcNAc-Ins. The enzyme M hA2 is yet to be identified. 
1.3.2 MshB 
MshB is homologou to the mycothiol-dependent detoxification enzyme mycothiol 
conjugate arnidase (Mca) and was identified as the fir t committed enzymatic step 
involved in the mycothiol biosynthesis (25). Results obtained from the study of MshB 
bowed that it ha a high pecificity for GlcNAc-Ins and it does not show the large 
spectrum of deacetyla e or amidase activity relative to its homolog, Mca. It was found 
that there is almo t lO x more GlcNAc-ln than GlcN-lns present inside the cell. This 
suggests that MshB could be the control point in the mycothiol biosynthesis pathway 
and that large quantities of mycothiol could be produced on demand through the 
deacetylation of the reservoir of GlcNAc-Ins. 
8 
Stellenbosch University  https://scholar.sun.ac.za
Chapter 1: Introduction 
In subsequent MshB disruption studies it was confirmed that MshB is responsible for 
the deacetylation of GlcNAc-lns and thus the synthesis of mycothiol (26). It was also 
discovered that although a mshB deficient strain of M smegmatis produced lesser 
amounts of mycothiol than the non-mutant strain, the production of mycothiol did not 
stop altogether. It was suggested that the basal levels of mycothiol present in the 
mutant strain could be contributed to the activity of Mca, but overexpression of Mca 
in the mutant strain did not increase the amount of mycothiol. This also showed that 
MshB is not essential for M tuberculosis growth. 
Maynes et al. first solved the crystal structure of MshB and also proposed a catalytic 
mechanism for the deacetylation activity, which was later confirmed by another study 
(27, 28). The deacetylation follows the well known general acid-base catalysis 
(GABC) mechanfam. The crystal structure of MshB, first solved by Maynes et al. in 
2003 (27), supported this general mechanism. MshB is a metalloprotein that is 
dependant on a Zn2+ ion for its deacetyla e activity. The metal ion is pentavalent 
coordinated with the Hisl3, Asp16, Hisl47 residues of MshB as well as two water 
molecules. 
H O CH20H 
~N OH 
O JAii~ OH 
)lo---- H-X~ :----HN;{H1s144 
/ ' 1 IJ:N'§ Asp146 
Asp15 ' I H · - ~ ' 2• ..__ 
/Zn, --() 
/ I ' 
// I ', 0 
His13 : His147 
Asp16 
Scheme 1.3: atalytic mechanism for MshB as proposed by Maynes et al.(27) 
The propo ed catalytic mechanism for MshB is shown in Scheme 1.3. As a.-GlcNAc-
lns bind to MshB the one water molecule coordinated with the Zn2+ ion is replaced by 
the carbonyl oxygen of the acetyl group (27), leaving the second water molecule in a 
good position for a nucleophilic attack on the carbonyl carbon of the acetyl group. 
The nucleophilic attack is assisted by the base carboxylate of Aspl5. A transition state 
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where the negatively charged oxygen is stabilized by the Zn2+ ion and irnidazolium of 
His 144 has been proposed. In the last step of the deacety lation, proton transfer to the 
nitrogen of a-GlcN-Ins is mediated through the acid function of Asp15. The reported 
crystal structure architecture and function were later confirmed by another study by 
McCarthy et al., 2004 (28). 
1.3.3 MshC 
MshC is encoded for by the gene Rv2130c or mshC. This gene was previously named 
cysS2 becau e it was thought that the gene encodes for a second copy of the cysteinyl-
tRNA syntheta e in the M tuberculosis genome. The true identity of cysS2 was 
discovered in a tudy where an enzyme showing MshC activity was purified from M 
smegmatis cell ly ate (29). Jn a homology search of the N-terminal sequence of this 
enzyme against the M tuberculosis genome, cysS2 was the only significant sequence 
found with a 80% homology for a 20 amino acid N-terminal sequence. These findings 
were conurmed when cysS2 wa cloned and expressed to produce an enzyme with 
Msh activity. Although MshC is not a cysteinyl-tRNA synthetase, MshC and CysS 
share a couple tructural similarities. Both Msh and Cy S have the HIGH and 
K.MSKS motif: con erved in all class I aminoacyl-tRNA yntheta e . Although the 
obvious relationship between the e two enzymes, the M smegmatis MshC enzyme 
wa found to be active in di- and tetrameric states under different phy iological 
condition . ysS is normally active a a monomer. 
The ligation of cysteine to aGlcN-lns can be divided into two half reactions (Scheme 
1.4) (30). Ln the first half (a) of the reaction ATP fir t bind to M hC followed by 
cysteine ( y ), forming an M bC-ATP-Cys complex. M hC releases a pyropho phate 
molecule upon formation of the cy teine-adenylate compound which is till bound to 
the active site. Jn the second half (b) of the reaction a.GlcN-In bind to M hC and the 
amide bond between aGlcN-Ins and Cys is formed with the cleavage of the adenylate 
anhydride, resulting in Cys-aGlcN-Ins and AMP. The order in which Cys-aGlcN-Ins 
and AMP is relca ed from the active site is yet unknown but if considering the 
catalytic mechani m of CysS it is postulated that Cy -aGlcN-In is released prior to 
AMP. 
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cheme 1.4: Proposed mechanism for the cysteine Lran fer to GlcN-lns by Msh . 
1. 3.4 MshD 
MshD belongs to the G NS-related N-acetyltran ferases (GNAT), which catalyzes 
the transfer of the acetyl- oA (AcCoA) acetyl group to a free amine. The gene 
encoding for MshD, Rv0819 or mshD, was also identified while studying MSH 
deficient M smegma/is mutants (31) . MshD's sequence is twice the length of the 
characteristic NAT protein, because it consi t of two tandem-repeated GNAT 
domain on the N- and -terminals. Of the two domains, the C-terminal domain has a 
higher imilarity with other GNAT proteins, suggesting that this domain is involved 
with Ac oA binding. In a later tudy it was determined that both domains bind acetyl-
CoA (32), although the binding sites are different. The C-terminal domain's active 
site is very similar to that of other GNAT proteins. AcCoA bind to this domain in 
uch a way, that the acetyl group is presented in the open active site. The active site is 
a solvent expo ed groove between the N- and C-terminal domains. AcCoA bind to the 
N-terminal domain so that the acetyl group is buried and not po itioned for acetyl 
transfer. These findings are all ba ed on the crystal structure of MshD, which was 
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determined in the presence of AcCoA and coenzyme A (CoA). This was also the first 
crystal structure solved for a mycothiol biosynthesis pathway enzyme. 
The structure of the MshD-AcCoA complex showed that the active site groove is 
much larger than required for Cys-aGlcN-Ins substrate binding (32). Further crystal 
structure studies performed with the bound substrate showed that MshD undergo 
conformational changes in which the two GNAT domains are brought closer together, 
resulting in new interactions between the domains (33) . Several of these interactions 
are mediated by the bound substrate. The size of the groove is reduced to a narrow 
tunnel, thereby promoting catalysis. In the smaller active site the substrate free amine 
is positioned clo e and in the correct orientation towards the acetyl group of AcCoA 
for nucleophilic addition of the amine on the carbonyl of the acetyl group (Scheme 
L.5). Glu234 acts a a general base through interactions with a water molecule, and 
accepts a proton from the free amine of Cys-GlcN-Ins. The AcCoA acetyl group is 
kept in position through hydrogen bonding with the amide backbone of Leu238. This 
interaction would also stabilize the tetrahedral intermediate. After acetyl tran fer the 
sulfhydryl of oA i protonated by the Tyr294 re idue. Thi proposed catalytic 
mechanism i common in many GNAT enzymes. 
l Glu234 I l \.o r. o 0 0 I 
,I 0 p 
/ 0 Cya-OICN·ln• H / ~ ,.< 0 H N \ SH 0 
):iH ' 
N SH N-f SH r HO 
" H.-i'H 
HOH t NH 
H .. \ 0 -?' 
Leu238 NH 
" 0 NH····· ··· 
--
AeCoA 
NH 
·o $ 
I $ $ 
ftOH 
! 
0 ···· H 
'"'°O ~ H ~ Tyr294 
Scheme 1.5: Propo ed catalytic mechani m for MshD 
This cry ta! tructure tudy also revealed that AcCoA is presently bound to the N-
terminal domain and doe not exchange with the olvent. This means that the cofactor 
was incorporated during protein folding and it i po tulated that the AcCoA structure ,,,,.~ 
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helps with protein stability. This feature is unique to MshD and is not seen in other 
GNAT enzymes (33). 
1.4 Drug targets and evaluation methods 
Mycothiol performs critical functions within the mycobacterial cell and it is clear that 
the enzymes involved in the MSH metabolism are potential drug targets against M 
tuberculosis. The bio ynthetic enzyme appear to be the most attractive targets, with 
most of the enzyme e sential for the survival of M tuberculosis. MshA, MshC and 
MshD are required for the production of MSH and consequently, the inactivation of 
their gene i lethal and severely limit the urvival of M tuberculosis. Inactivation of 
mshB reduce the production of MSH and through the Mca production of GlcN-Ins, 
the cell is still able to ynthe ize M H and urvive. Furthermore, Mca deficient M 
smegmatis mutant are more susceptible to antibiotics and the inactivation of Mtr 
reduce the growth of M tuberculosis. 
Thu far, most of the efforts involving inhibitor design again t the abovementioned 
enzyme have gone towards de igning inhibitor and sub trate analogue again t Mca. 
The e will be fully discussed in hapter 4. Al o, the homology between Mca and 
MshB sugge ts that some mycothiol-related molecules may show activity with both 
enzymes. I Lowever, this has only been shown to be the case for a limited number of 
compounds, and other hould thus be tested in a similar fashion. 
La tly, current assay methods employed for the screening of inhibitors and substrate 
analogues again t Mca and MshB all involve derivati ation technique followed by 
I ILP -UV analy is. These technique seriously re train the efficiency of inhibitor 
screening and will be di cu ed in Chapter 3. 
1.5 Conclusion 
With the emergence of MDR- and XDR-TB, tuberculosis ha become an ever greater 
health problem worldwide, especially in developing countries. The need for faster 
development of new drug candidates against TB i therefore al o growing. In our 
tudy we aimed to improve the efficiency by which potential new drugs can be 
screened for activity against exi ting targets in the mycothiol pathway and any other 
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mycothiol dependent processes. For the successful development of a drug discovery 
protocol and the improvement of existing assay methods a few basic tools are needed. 
They are: key enzymes, better analytical methods and easily accessible substrates or 
substrate analogues. In this study we aim to work toward a drug discovery protocol 
(Scheme 1.6) for the development of inhibitors or substrate analogues against 
abovementioned enzymes. We intend to use MshB's substrate specificity, as a 
primary screen for scaffolds that display binding modes similar to its natural substrate, 
aGlcNAc-Ins. Enzyme kinetic data along with computational molecular modeling 
will be used as a guide to build inhibitor libraries for all downstream enzymes in the 
MSH pathway, in particular Mtr. Hence, compounds that show adequate activity with 
MshB would be further derivatised to serve as either substrate analogues or inhibitors 
for Mtr, a well a the other MSH pathway enzymes. Compounds that show 
encouraging activity with MshB will be subjected to further modification in order to 
optimize binding with MshB. 
lnhih1ior 
Suhstrotc nnlogs 
] ' ubscqucnt impro\cmcnt 
L- -1> ,__( l'_rcscrccn_,,O ,.----~ 
cheme 1.6: Propo ed drug discovery protocol. 
h1nhcr dc\elopment 
through dem nti tion 
. crcening against 
. peci fie targ L~ 
In Chapter 2 we will report the expression and purification of the enzymes crucial to 
this study. The recombinant expres ion of Mtr in E. coli was for the fir t time 
successfully performed during this study. urthermore, we will di cuss the 
development of a llPL - Sl/MS(TO ) method for the quantitation of mycothiol 
pathway intermediates in Chapter 3. The synthe i of ubstrate analogues against the 
expre sed enzymes and their evaluation will be discussed in Chapters 4 and 5 
respectively. 
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Chapter 2 
Cloning, expression and purification of M. 
tuberculosis mycothiol related enzymes 
2.1 Introduction 
As discus ed in Chapter 1, MshB is the second enzyme in the mycothiol biosynthetic 
pathway (1). This enzyme catalyses the deacetylation of GlcNAc-lns to produce 
GlcN-Ins, the econd intermediate in the pathway. Mycothiol Disulfide Reductase 
(Mtr), is responsible for the reduction of the mycothiol disulfide (MSSM) to produce 
two equivalents rnycothiol (MSI-1) (2) . The gene sequences of both MshB and Mtr are 
known, the e being Rvl 170 (mshB) and Rv2855 (mtr) re peetively. This makes it 
possible for these genes to be amplified from M tuberculosis genomic DNA and 
cloned into expres ion plasmids for overexpre sion and sub equent purification. In 
this chapter we report the expre ion and purification of both the MshB and Mtr 
enzymes. 
2.2 MshB 
Previously M hB wa cloned into and expre ed using the pET22b(+) expression 
plasmid (1, 3, 4). This expre sion plasmid is part of the pET System (Novagen) of 
expression plasmid used to clone and express recombinant proteins in E. coli. When 
using pET22b(+), proteins are expressed connected to a C-terminal 6 x Histidine tag 
(llis6-tag). ln this study MshB was cloned and expressed using pET28a(+), which is 
also part of the pET System. With pET28a(+) one has the option of expre sing the 
recombinant protein with a C- or N-terminal His-tag. MshB was previously expressed 
with a C-terminal His-tag. 
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2.2.1 Cloning and expression 
The Rv 1170 or mshB gene was amplified from genomic M tuberculosis H3 7R v DNA. 
During amplification an N-terminal Ncol-site and a C-terminal Xhol-site was 
introduced, which made it possible for the PCR product to be cloned into pET28a(+) 
(Novagen pET expression system) in such a way that MshB would be expressed with 
a C-terminal 6 x histidine tag (His-tag). The His-tag has a high affinity and binds to 
Ni2+ ions, which makes the purification of the protein possible through immobilized 
metal affinity chromatography (!MAC). The formation of the pET28a(+)-mshB 
expression plasmid was verified through digestion screening. 
Expression trails were conducted to find the correct combination of express10n 
parameters for oluble expression. These parameters are: the concentration of 
isopropyl-P-D-thiogalactoside (IPTG) used to induce expression, the temperature at 
which expre ion cultures were incubated after induction and the time allowed for 
expre sion to continue. The expression trails were performed in E. coli BL21 *(DE3). 
The expected results were achieved after the expression wa left overnight at 22°C 
and more pecifieally at an IPTG concentration of O. lmM (Figure 2.1). 
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Figure 2. 1: Ex pre sion trail of pET28a(+ )-mshB at 22°C, overnight and different IPTG concentrations (as 
indicated). 
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2.2.2 Purification of MshB 
The expression conditions discovered above were used in a large scale expression (see 
2.5.4.2) of MshB-His. The purification from bacterial lysate was performed using the 
automated AKTAprime-system with a lml HisTrap FF column (Amersham 
Bioscience). The HisTrap FF column is Ni-NIA-based and thus preloaded with Ni2+ 
ions. The program used to purify the protein was an automated gradient run. Before 
the protein was loaded onto the column, the column was equilibrated with 10 column 
volumes of I-hO and 5 column volumes of binding buffer (20rnM Tris-HCl, 5rnM 
imidazole, 500mM NaCl, pH 7). After protein loading a wash step with 10 column 
volume binding buffer followed before another 5 column volumes wash step in 
which the elution buffer (20mM Tris-HCl, 500mM NaCl, 50mM imidazole, pH 7.9) 
concentration was increa ed to 15%. This second wa h step was necessary to elute 
any nonspeci{ically bound protein . The MshB-His protein was eluted by increasing 
the concentration elution buffer to l 00% over 10 column volumes. A flow rate of 
I ml/min was maintained over the run and protein elution wa monitored at 280nm. 
The protein concentration wa determined with a Bradford assay to be 4.5mg/rnl. 
2.3 Mycothiol Disulfide Reductase (Mtr) 
Mtr was previou ly cloned into and expre sed from the mycobacterial expression 
plasmid, pMV261. M smegmatis was used as expre sion ho t (2, 5, 6). During this 
study various method of cloning and expression were u ed in an attempt to olubly 
express Mtr in E. coli a expression host. The p T28a(+) expre ion pla mid was 
used to expressed Mtr with a C- and N-terminal Bi -tag. The Gateway® expression 
sy tern was used to expre Mtr with different fu ion protein tags. 
2.3.l Cloning and Expression of Mycothiol Disulfide Reductase with a 
N-terminal His-tag 
The mtr gene was amplified from M tuberculosis H37Rv genomic DNA. An N-
terminal Ndel-site and a -terminal Xhol- ite were introduced, which was used to 
clone the P R product into pET28a(+) (Novagen p T expression system). Using the 
Ndel and Xhol sites ensures that Mtr will be expressed with an N-terminal 6 x 
histidine tag (His-tag) for purification through IMAC. The pET28a(+)-mtr construct ,,,...-
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was verified with restriction enzyme analysis and sequencing. E. coli BL2l(DE3) was 
used as expression host. The first expression trails were performed in the same 
manner as for MshB-His, but no soluble His-Mtr was obtained (Figure 2.2). 
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Figu re 2.2: Fir t pET28(+)-mtr expression trail performed at 22°C, 4h and overnight, and at different 
IPTG concentrations (noted in the figure) 
2.3.2 Other attempts at soluble expression and purification of His-Mtr 
2.3.2.1 Addition of Ethanol and Gly-Gly 
It has been demonstrated that the addition of ethanol and gly-gly could help improve 
the solubility of otherwise insoluble proteins (7, 8). E. coli Bl2l(DE3) cells 
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containing the pET28a( + )-mtr construct was induced to express His-Mtr rn the 
presence of 0.5%, 1.0% and 1.5% ethanol and I.OM gly-gly, which was added to the 
growth media. Unfortunately, no soluble His-Mtr was obtained. 
2.3.2.2 Co-expression with pRARE plasmids 
The pRARE 2 plasmid encodes for tRNAs of scarce codons. Scarce codons are the 
codons whose tRNA's is not usually used by E. coli for the translation of its native 
RNA to protein. It has been shown that the introduction of the tRNAs of these scarce 
codons (AUA, AGG, AGA, CUA, CCA, GGA and CGG) improve the translation 
efficiency, which lead to soluble recombinant protein (9). 
In the translation of the mtr gene 25 scarce codons (3AUA, lAGG, 4CUA, 6GGA and 
l lCGG) are used (Graphical Codon Usage Analyser, 
http://gmmmcua.schoedl.de/sequential_ v2.html). In order to provide the tRNAs of 
these ca.rec codons, the pET28a(+)-mtr plasmid was co-expressed with the pRARE2 
plasmid that expresses the tRNA of all seven scarce codons mentioned here. 
l lowever, the co-expression did not solve the insolubility problem. 
2.3.2.3 a-expression with Chaperone Plasmids 
In another attempt to olublilize llis-Mtr the pET28a(+)-mtr plasmid was co-
expre sed with a series of five chaperone plasmids (Takara Bio Inc.). Each of these 
chaperone pla mids encode for a different "team" of molecular chaperone proteins 
(Table 2.1 ), which was shown to improve the solubility of recombinant proteins (I 0, 
11). 
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Table 2. 1: Takara Chaperone Plasmid sets 
Plasmid Chaperons Promoter inducer Resistance 
pG-KJE8 dnaK-dnaJ-grpE- araB and Pzt I L-arabinose Cloramphenicol groES-groEL Tetracycline 
pGro7 groES-groEL araB L-arabinose Cloramphenicol 
pKJE7 dnaK-dnaJ-grpE araB L-arabinose Cloramphenicol 
pG-Tf2 groES-groEL-tig Pztl Tetracycline Cloramphenicol 
pTf\6 tig araB L-arabinose Cloramphenicol 
Molecular chaperone proteins prevent the aggregation of insoluble proteins, called 
inclusion bodies, by a sisting them to fold correctly into their tertiary structure (I 2). 
Thi pla mid set uses six different chaperone and co-chaperones in different 
combinations. Trigger factor or tig is a 50k.Da E. coli protein that was shown to have 
Peptidyl-prolyl cisltrans isomcra e (PPla e) activity and was found to be associated 
with the SOS ribosome subunit (I 3, 14) . These PP lases catalyzes the ci -trans 
isomerization of prolinc imidic bonds in newly ynthesized peptides, thus helping 
with protein folding (15) . DnaK belong to the Hsp70 family of heat shock proteins. 
All the member of this family have two domain , a -terminal peptide binding and 
N-terminal A TPase domain (16). GrpE and DnaJ are two co-chaperone that are 
e sential for DnaK activity. While GrpE promotes nucleotide exchange by DnaK, 
DnaJ helps with the binding of DnaK to the target polypeptides (16, 17). GroES is a 
type I chaperone which also helps with protein refolding in conjunction with a co-
chaperone like Gro L. During the ATP dependent protein folding mechani m the 
target protein i enclo ed in the GroE ring structure by GroEL, after which it is 
released to the cyto ol (J 6, 18). 
The co-expression of p T28a(+)-mtr with the five different chaperone pla mids was 
performed at 37°C and 30°C for 4h respectively. The expre sion of Mtr wa induced 
with a final lPTG concentration of 0.5mM (Figure 2.3). The expression of the 
chaperons was induced with each re pective pla mid corresponding inducer (Table 
2.1). 
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Initial analysis suggested that soluble expression of His-Mtr was achieved by co-
expression with of the pTfl6 plasmid. Attempts at verifying these results through a 
large scale expression and purification failed as no significant amounts of purified 
protein was obtained. The flow through, wash and elution fractions were analyzed on 
a 12% SDS-PAGE gel, which showed no significant protein bands at 52k.Da. It was 
hereby concluded that His-Mtr was not soluble. The trigger factor has a molecular 
weight of 50k.Da and if overexpressed to the extent that it can be visualized on a SDS-
p AGE gel, it could explain the bands mistaken for soluble His-Mtr. 
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Figure 2.3: Expression trail where pET28a(+)-mtr was co-expressed with the different chaperone 
pla mids. The trails were conducted at 30°C and 37°C respectively; expression was induced with 0.5mM 
!PTG and allowed to continue for 4h. 
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2.3.2.4 Attempted Solublisation with Emu/gen® 
Emulgen® is used in the purification of cyctochrome P450 enzymes from yeast (19) or 
animal liver cell micro omes (20). We used Emulgen® 913 (Kao Corporation) as 
described by Hara et al. (19) in an attempt to solubilise His-Mtr from the whole cell 
fractions. However, no soluble protein was obtained (data not shown). 
2.3.3 Cloning and expression of Mtr with fusion protein tags 
Another method by which insoluble recombinant proteins could be solubilised is by 
means of expressing the target protein connected to a fusion protein tag (21). During 
this tudy we used the Gateway® Expression System (Invitrogen) which allows you to 
create a wide range of expression plasmids, all with different fusion protein tags. The 
target gene is cloned into an entry plasmid, which is then used in a gene transfer (LR) 
reaction with different destination pla mid (containing the fusion protein tags), 
creating a eries of expression pla mid . 
The mfr was cloned into two different entry pla mids, pENTR4N and pENTR4NT. 
The pENTR4N-mtr con tructs were u ed in LR reaction with five different 
destination plasmids: pD "' STl 5, pD T532, pD ST544, pD ST566 and 
p Tl60DEST (Table 2.2). The re ulting expression vectors were verified by 
restriction enzyme analy i with the B pl4071 enzyme. 
Table 2.2: ateway destination plasmid u ed and their corre ponding expre sion plasmids 
Destination Expression Recombinant 
Fusion tag Inducer 
Plasmid Plasmid Protein ize 
pDE Ti5 GT pEXP15-mtr TPTG 76k.Da 
pDE T532 His-GB! pEXP532-m/r IPTG 57kDa 
pDEST544 Hi -NusA p XP544-mtr IPTG 104k.Da 
pD T566 His-MBP pEXP566-mtr IPTG 94kDa 
pET160D ST His pET! 60EXP-mtr IPTG 52kDa 
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2.3.3.1 Expression attempts 
Expression trails were performed with pEXP544-mtr, pEXP15-mtr and pEXP566-mtr. 
The trail with pEXP544-mtr and pEXP15-mtr did not produce soluble expression of 
the fusion-tag Mtr proteins. In the trails with pEXP566-mtr it seemed like the His-
MBP (Maltose binding protein) tagged Mtr protein was expressed soluble (Figure 
2.4). 
w .. 
199== 
120-
'~== 
70-
60-
~o-
10-
10-
2~-
20-
\\'hole cell cn1dc cwuct Cell free crude C'itract 
10 II 12 IJ 
I. I (hnM ll'IC1l.0.75rnM ll'IC1 3. O.~rnM 11'1<1 -I. 0.2m\1 ll'll1 5. O. lm\111'1(16. 
0.0SmM II' I Ci 7. l'JpcRuler Pmtcin I llddcr(I crnicnhL') ll. l.Om~l ll'l'<l 9. 0.75mM 
ll'IC110.0.5111MIPICi l l.0.2111\.lll'IC1 l l.O. lmMll'ICi 1 3.0.0~mMll'IG 
Figure 2.4: p ~XP566-mtr expression trail performed at 37° , 3h and different IPTG concentrations (as 
indicated). 
A large scale expre sion and purification, with the AKTAprime-system, of the His-
MBP-Mtr f u ion protein wa attempted. Expression was induced with a final IPTG 
concentration of 0.75mM. Subsequently, the expression was allowed to continue for 
3h at 37°C. A very small elution peak was obtained during the purification. The 
elution fractions were analyzed on a 12% SDS-PAGE gel. The same 94kDa band (as 
hown in Figure 2.4) wa present in addition to a large amount of other proteins which 
eluted in the same fractions. 
Another expression trail was performed to investigate if the time allowed for 
expression after induction had an influence on the amount of His-MBP-Mtr present in 
the cell free extracts. The trail was performed at 37°C with a final IPTG concentration 
of 0.75mM. Expression was allowed to continue for 3, 5, 7 and 16h (overnight) 
respectively. The best protein expressions were obtained at 3 and Sh. Another large 
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scale expression and purification was attempted whereby Sh were allowed for 
induction. The results were similar to those described above. 
It was then decided to co-express His-MBP-Mtr with the chaperone plasmids, to 
investigate if it would improve the amount of soluble protein expression. After 
numerous attempts to transform competent E. coli Bl21(DE3) containing pEXP566-
mtr with the chaperone plasmids (Table 2.1), only pG-Tf2, pG-KTE8 and pGro7 could 
be successfu lly transformed. Expressions were performed as described in 2.3.2.3. 
Unfortunately there wa no improvement in the amount of protein expressed. 
2.3.4 Mtr expression with a C-terminal His-tag and subsequent 
purification 
All perviou attempts to expres oluble Mtr with N-terminal tags have failed, thus 
soluble expre sion was attempted with a C-terrninal His-tag using pET28a(+) as 
expres ion plasmid. A new set of P R primer were designed that introduce an N-
terminal Ncol-site and a C-tcrminal Xhol-site during the PCR amplification of the mtr 
gene. Thus, when cloned into pET28(+)a, Mtr would now be expressed with a C-
tenninal His-tag. The pET28a(+)-mtr T expression plasmid was verified through 
digestion screening. Expression trails were conducted at 37°C and 22°C, overnight 
and at different IPT concentration as indicated in Figure 2.5. Soluble Mtr-His 
expression was seen in both expression trails. 
The 0.1 mM and 0.05mM cell free extracts of the 22°C expre ion trail wa purified 
using a Hi pinTrap ( E Healthcare) and analyzed on a 12% SDS-PAGE gel, in 
which soluble Mtr-Hi was seen as a faint band at 52kDa (data not hown). A 
relatively large scale expre ion wa performed at 22°C for 16h, using a final IPTG 
concentration ofO.lrnM, followed by purification on the AKTAprime-system using a 
lrnl HiTrap® Chelating HP column (Amersham Bioscience). This column is Ni2+-IDA 
based which requires the loading of Ni2+ onto the column as part of the AKTAprime 
automated program. 
A self-programmed gradient run, with a Oow rate of 1 ml/min, was used to purify Mtr-
His. After the column was equilibrated with 5 column volume of H20, Ni2+ was 
loaded onto the column by washing it with 5 column volumes of a lOOmM NiS04 
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solution. This was followed by a wash step with 5 column volumes H20 and before 
the protein was loaded the column was again equilibrated with l 0 column volumes of 
binding buffer (20mM Tris-HCl, 5mM imidazole, 500mM NaCl, pH 7). Another wash 
step of 10 column volumes binding buffer followed after the protein was loaded. The 
non-specifically bound proteins were eluted with 10 column volumes binding buffer 
in which the elution buffer (20mM Tris-HCl, 500mM NaCl, 50mM irnidazole, pH 
7.9) concentration was increased to 15%tlv). Mtr-His was eluted by increasing the 
concentration of the elution buffer to 100% over 10 column volumes. Protein elution 
was detected at 280nm. The protein concentration was determined to be 0.80mg/ml by 
means of a Bradford assay. 
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Figure 2.5: Expression trnil of pET28( t )-mtrCT at 37°C and 22°C, overnight and different IPTG 
concentrations (as indicated). 
29 
Stellenbosch University  https://scholar.sun.ac.za
Chapter 2: Cloning, expression and purification of M tuberculosis mycothiol related enzymes 
The flow through, wash and elution fractions of the purification run, was analyzed on 
a 12% SDS-PAGE gel (Figure 2.6). Although some of the soluble Mtr-His was lost in 
the wash (elution of non-specifically bound proteins) step, there was still a sufficient 
amount of bound protein on the column for an acceptable yield. 
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Figure 2.6: SDS-PAGE analy is of the purification of soluble Mtr-His. 
2.4 Conclusion 
2.4.1 MshB 
Jn our tudy MshB was expressed using the pET28a(+) expression plasmid. Also, the 
purification techniques u ed here allowed for better purification of MshB-llis and thus 
gave rise to larger yields (almost nine times) of soluble MshB-His than previously 
achieved ( 4). 
2.4.2 Mycothiol disulfide reductase 
Mycothiol disulfide rcductase was successfully cloned, expressed and purified during 
this study. Previously this could only be achieved by using M smegmatis as 
expression ho t (2, 5, 6). Sy terns for the expression of recombinant proteins in M 
smegmatis are not nearly as effective as in E. coli, as was proven during this study. 
Patel and Blanchard (2) could only manage to purify 2.9mg of Mtr from SL of M 
smegmatis culture with a long, multi-step purification procedure. During this study a 
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total of 21.8mg Mtr-His was purified from 2.5L of E. coli culture using a simple, 
automated procedure. Currently we are attempting to solve the crystal structure of 
Mtr in a collaborative effort. If successful, it will be the first crystal structure of Mtr 
and would be a major breakthrough for the structure based design of drugs targeting 
this enzyme. 
2.5 Experimental 
2. 5.J DNA amplification 
2.5.J.l Mycothiol Disulfide Reductase (MSSMR) 
The Rv2588 or mtr gene was amplified from genomic Mtb DNA strain H37Rv using 
the forward primer 5'-GCCCCTACATATGGAAACGTACG-3' and the reverse 
primer 5'-AG CAGCTCGAGAGG AGAGG-3'. With these primers an Ndel 
(underlined) restriction enzyme site is introduced in the forward primer and an Xhol 
(underlined) restriction enzyme site in the reverse primer. The amplification reaction 
mixture wa set up as follows: Pfu buffer, 0.4mM dNTP mix, 1 rnM forward primer, 
lmM revere primer, lng genomic DNA, varied MgS04 concentration , l.25U Pfu 
and di tilled, deionized water (ddH20) to a final volume of 25µ1. The PCR program 
had an initial step of 2 min at 94°C; followed by 30 cycles of denaturation at 94°C for 
15s, annealing at 60° for 30s and polymerization for lmin at 70°C. After the 30 
cycles were completed there was a final polymerization tep of 6 min at 70°C and the 
program ended with a hold step at 4°C. The reaction mixtures were visualized by gel 
electrophoresis on a I% agarose gel and staining the gel with SYBR®gold. The bands 
were viewed on a Darkreader. The best product band at l 522bp was obtained at an 
MgS04 concentration of 3 µM. The product band was purified out of the gel using the 
Eppendorf Perfcctprep Gel Cleanup kit. Thi PCR product was used in the 
construction of the p T28a-mtr, pENTR4-mtr and pENTR4N-mtr plasmid . 
For the construction of the pET28a-mtrCT pla mid a new set of primers had to be 
designed, allowing the pla mid to be constructed in such a way that will make it 
possible for MSSMR to be expressed with a C-terminal histidine tag (His-tag). The 
forward primer 5'-GATGGCCCCTACCCATGGAAACGTACG-3' introduced an ,,,,-
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N col (underlined) restriction enzyme site and the reverse pruner 5 ' -
GCTCGCCGTTGCTCGAGACGCAGGCCAAG-3' an Xhol restriction enzyme site. 
The same amplification reaction mixture was used for this PCR reaction, but different 
annealing and polymerization temperatures were used, 65°C and 77°C respectively. 
The reaction mixtures were visualized and the product band purified as described 
above. The best results were obtained at a MgS04 concentration of 3.5µM. 
2.5.J.2 MshB 
The Rvl 170 or mshB gene was amplified from genomic Mtb DNA strain H37Rv 
using the forward primer 5'-GGTGCCTCCATGGCTGAGACGCCGC-3' which 
introduce an Ncol (underlined) restriction enzyme site. The rever e primer 5'-
CCTGGTT G CTCGAGCGTGCCGGAC-3' introduces an Xhol (underlined) 
restriction enzyme site. This primer set allows the pET28a-mshB construct to express 
MshB with a C-terminal His-tag. The amplification reaction mixture was setup as 
previously mentioned. The PCR program used an annealing temperature of 73°C and 
a polymerization temperature of 80°C. The reaction mixtures were visualized and the 
product band purified as previously de cribed. The best result were obtained at a 
MgS04 concentration of 2µM. 
2.5.2 Restriction Digests 
The mtr P R product, pET28a(+), pENTR4N and pENTR4NT were digested with 
Ndel and Xhol restriction enzymes (both form Ferrnentas). The 20µ1 digestions 
reactions were performed m ermentas Buffer R containing BSA, 15µ1 PCR 
producUplasmid, JOU Ndel and 20U Xhol. The reactions were incubated for 2h at 
37°C, after which the mixtures were vi ualized on a 1 % agaro e gel and the bands of 
correct size purified using the Eppendorf Perfcctprep Gel Cleanup kit. 
The mtrCT P R product, m hB P R product and pET28a(+) dige tion were 
performed with Ncol (New ngland Bio Labs) and Xhol. In the e reaction 14µ1 PCR 
producUpla mid and 20U Ncol were used. The relevant bands were visualized and 
purified as described above. 
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2.5.3 Plasmid Construction 
During this study two expression systems were used, pET (Novagen) and Gateway 
(lnvitrogen), and the construction of their expression plasmids was carried out in 
different ways. In the pET system the PCR product was directly ligated into the 
expression plasmid. With the Gateway system the PCR product was first ligated into 
the entry plasmids, and thereafter expression plasmids were created by means of the 
Gateway LR reaction. 
2.5.3.1 pET expression system 
Only the pET28a(+) expression plasmid was used. Equal amounts of restriction 
digested plasmid and PCR product were added together in a volume of 5µ1. Quick 
Ligation Reaction Buffer and IOU Quick T4 DNA Ligase (New England BioLabs) 
were added to the plasmid/PCR product mixture to make a final volume of 10.5µ1. 
The reaction was incubated for 5min at room temperature. The reaction mixture was 
then tran formed into chemically competent E. coli Mach! cells and plate on Luria 
Bertani (12) plates containing 30mg/I kanamycin. The e plates were incubated 
overnight at 37°C. The colonic were screened using the Colony Fast Screen kit 
(Epicentre). A smear of a colony was added to 25µ1 of EpiLyse solution l and mixed. 
After 10µ1 piLyse solution l was added the mixture was vi ualized on a 1 % agarose 
gel, using the parent p T28a(+) as reference. Only the DNA samples that appeared 
larger than the p T28a( +) reference were subjected to further creening. Overnight 
cultures were grown from the colonie containing the target plasmid . Plasmids were 
purified from these culture using the Zyppy Plasmid Miniprep I Kit (Zymo Research) 
and analyzed with a restriction digestion reaction. The same restriction enzymes were 
used, as for the digestion of the corresponding PCR product. The reactions were 
visualized on a 1 % agarose gel and if the desired band pattern was obtained, the 
plasmids were tocked for further u e. 
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2.5.3.2 Gateway expression system 
2.5.3.2.1 Entry Plasmids 
The pENTR4N and pENTR4NT entry plasmids were used. The ligation of the mtr 
PCR product into the two plasmids was performed in the same manner as for the pET 
expression system. The transformation and first and second rounds of screening were 
also performed as mentioned above. The only difference with the abovementioned 
methods is that, after the transformation of the mtr PCR product/pENTR4NT ligation 
reaction into E. coli Mach! cells, the cells were plated on LB plates containing 12mg/l 
tetracycline. Pla mids that passed the creening methods were stocked for further use. 
2.5.3 .2.2 Gateway LR reaction 
The Gateway ystem utilizes an expression plasmid that is created through means of a 
LR reaction. In this reaction a recombinant entry plasmid (2.5.3.2.1), destination 
plasmid and LR clonase are added together. The entry and destination pla mids both 
have att-sites and the DNA between these sites is exchanged during the LR reaction. 
1n the recombinant entry plasmid the target gene sequencing is ituated between the 
att-site . ln this sy tern, colonie containing the required expression plasmids are 
selected for with two method , namely by means of a ccdB-suicide gene contained 
between the alt- ite of the destination pla mid and the ampicillin resistance of the 
destination plasmid. Thus after a LR reaction cell containing de tination plasmids 
would not urvive because of the uicide gene. Thi i also true for cell containing 
the recombinant entry pla mid because of resi tance to kanamycin or tetracycline and 
not ampicillin. Only cel l containing the newly formed expres ion plasmid would 
survive. 
A de ti nation pla mid (pDEST) and an entry plasmid were added together in a 3: 1 
ratio and a final volume of 3µ1. To the latter was added 1µ1 of LR clonase buffer and 
1µ1 of LR clona e and incubated at 25°C for 4h. The reaction was terminated by the 
addition of lµl Proteina e Kand incubation at 37°C for IOmin. The reaction mixture 
was then tran formed into E. coli Machi cell , plated on 1 OOmg/I ampicillin 
containing LB plate and incubated overnight at 37°C. Overnight cultures were grown 
from selected colonies; the plasmids purified u ing the Zyppy Plasmid Miniprep I Kit 
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(Zymo Research) and analysed through resistriction enzyme digestion. In these 
plasmid digestion reactions 20U of Bsp14071 (Ferrnentas) restriction enzyme, 
Fermentas Tango buffer and purified plasmid DNA was used to provide a final 
volume of 16µ1. The Bspl4071 enzyme cuts at the att-sites. Reactions were visualized 
on a 1 % agarose gel and thereafter SYBR®gold staining the bands were viewed with 
the Dark.reader. Plasmids with the required two band pattern were stocked for future 
use. 
2. 5.4 Protein expression and purification 
All expression were fir tly conducted in small scale expression trails to determine the 
correct combination of parameters for soluble expression of the target proteins. After 
optimization of these parameters, large scale overexpressions of the target protein and 
protein purification was attempted. All growth media and plates used in the 
expres ion of proteins contained the required amount of specific antibiotic. 
2.5.4.l Expression trails 
The desired expression plasmids were transformed into E. coli BL21 *(DE3) cells, 
then plated for an overnight cu lture grown from a single colony. The expression trails 
were performed in 2ml ppendor Lidsac tube . Each tube contained 1305µ1 LB or 
Al media, 150µ1 overnight culture and 45µ1 of lPTG to obtain a final volume of 
1500µ 1. Expre sion culture (growth media and overnight culture) were incubated at 
37° in a baking incubator. Culture were incubated until it reached an OD600 
reading of 0.6, after which IPTG wa added. The following parameter were varied to 
find the optimum conditions for soluble protein expres ion: 
I . The final IPTG concentration: lmM, 0.75mM, 0.5mM, 0.2mM, 0.lmM and 
0.05mM. 
2. Time allowed for expression to continue after induction: 4h or overnight. 
3. The temperature at which expression trials were conducted: 25°C, 30°C and 
37°C. 
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At the end of the expression trails the cells where harvested by centrifugation. The 
cell pellets were either processed directly after the trails ended or it was stored at -
20°C for later use. 
2.5.4.2 Large scale expressions 
For the large scale expressions 500ml LB media was inoculated with an overnight 
culture of E. coli BL21 *(DE3) cells containing the specific expression plasmid. 
Subsequently incubation proceeded at 37°C until an OD600 reading of 0.5-0.6 was 
reached. After the de ired amount of IPTG was added the expression culture was 
incubated according to the predetermined conditions found in the expression trails. 
Cells were collected through centrifugation at 4500g for 30rnin at 4°C. If the pellets 
were not proces ed immediately after collection they were stored at -20°C until use. 
2.5.4.3 Analyzes of expression trails 
The cell pellets obtained from the expression trails were re- u pended in 300µ1 
BugBuste protein extraction reagent (Novagen) and incubated for 20rnin at room 
temperature on a shaking platform. Cell debris was removed by centrifugation at 
13000g for 20min, afier which the upernatant wa transferred to a clean tube and 
analyzed on a DS-PAGE gel for oluble protein . The cell debri pellet was re-
suspended in 100µ1 elution buffer (lOmM Tri -II 1, pH 8) and analyzed for in oluble 
proteins on a DS-PA E gel. 
2.5.4.4 Protein purification from large scale expressions 
The large scale expre sion cell pellets where re- u pended in a volume lOx the weight 
of the cell pellet with binding buffer (20mM Tris-IlCl, 5mM imidazole, 500mM 
NaCl, pII 7). Cells were lysed by means of sonication and the cell debris separated by 
centrifugation at l 5000g for 30rnin at 4°C. The supernatant wa removed, followed by 
filtration with a Pall Acrodi c PSF GxF/GHP 0.45µm filter before it was injected into 
the AKT Aprime-system. 
The two protein were purified using the same His-tag purification procedure, the 
only difference being the columns used. MshB was loaded onto a lml HisTrap FF 
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column, whereas Mtr was loaded onto a 1 ml Hi Trap Chelating HP column, both from 
Amersham Bioscience. The difference between the two columns is that the FF column 
is supplied preloaded with Ni+2 and the Chelating HP column needs to be loaded with 
Ni+2 as part of the AKT Aprime program. After the His-tagged protein was loaded 
onto the column and non-specific bound proteins washed off, the irnidazole 
concentration in the buffer (20mM Tris-HCl, 500mM NaCl, 50mM irnidazole, pH 
7.9) was increa ed to elute the target protein. The eluted proteins were then desalted 
using a 5rnl HiTrap desalting column (Amersham Bioscience) and a gel filtration 
buffer (25mM Tris-HCl, 5mM MgCh, 5% glycerol, pH 8) on the AKTAprime-
system. All the protein elution profiles were followed by UV detection at 280nm. 
2.5.4.5 12% SDS-PAGE gel analysis 
Proteins, either from expression trails or large cale purifications, were visualized 
using 12% DS-PAGE gels. The protein samples were prepared by adding it to an 
equal volume of 2x SD -PAGE loading buffer (0 .125M Tris-HCI, 4% SDS, 30% 
glycerol, 1.5% ~-mcrcaptoethanol and bromophenol blue, pH 6.8) and incubating it • 
for 5rnin at 95° . After the sample were loaded the gel was run in lx SDS-PAGE 
running buffer (0.1 % D , 0.025M Tris and 0.192M glycine). After completion, gels 
were stained with ooma ie blue tain ( 45ml MeOH, 40ml ddl-120, l Ornl CH3COOH 
and 250mg Cooma ie Brilliant Blue) for 30min and then de tained for 2 hours with 
destaining solution (45% Me ll, 40% ddl!iO, 10% CH3COOH). 
2.5.4.6 Protein concentration determination 
oncentration determination wa performed using the Bradford protein as ay. Bovine 
erum albumin (B A) standard from Biorad were u ed to plot a tandard curve of 
ab orbance ver us concentration. Ab orbance wa measured at 595nm, which is the 
absorption maximum of the Coomassie Brilliant Blue dye when bound to protein. The 
dye is added to all protein amples, standards and unknowns, and incubated for 5rnin 
at room temperature before measurements are taken. All measurement were taken 
with a Thermo Varioskan™ and data processing was performed with Skanit software. 
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2.5.5 Other attempts at soluble protein expression and purification 
During this study it was necessary to perform protein expression and purification in 
different ways as stated in the previous section. None of the methods mentioned here 
was used for the large scale expression and purification of Mtr or MshB. All 
expression trails were performed in the 2rnl Eppendor:t® Lidaac tubes. 
2.5.5.1 Expression in the presence of glycylglycine and ethanol 
Expression trails were performed in LB media containing 0.5M or I.OM glycylglycine 
(Fluka) and in LB media containing 0.5-1.5% ethanol. The expressions were 
incubated overnight at 37°C. 
2.5.5.2 Scarce codons 
Competent cells were made from E. coli BL21 *(DE3) cells containing the pET28a-
mtr expression plasmid. The pRARE2 plasmid was then transformed into these 
competent cells and plated on LB plates containing 20mg/l chloramphenicol and 
30mg/l kanamycin. The expre sion was performed in AI media containing the 
abovementioned antibiotics. Expressions were allowed to continue overnight. 
2.5.5.3 Chaperone plasmids 
The five different chaperone plasmids were transformed into competent E. coli 
BL2 I *(D • 3) cell containing either the pET28a-mtr or pEXP566-mtr expression 
plasmids. The cell were plated on 20mg/I chloramphenicol and 30mg/l kanamycin 
LB plate . LB media was used for these expres ion trails which, in additions to the 
antibiotic , also contained 4mg/ml L-arabinose, lOng/rnl tetracycline or both. The L-
arabinose and tetracycline induces expression of the chaperon . Expres ion trials were 
incubated for 4h at 30°C and 37°C respectively after expres ion plasmid induction 
with IPTG. 
2.5.5.4 His SpinTrap columns 
These columns (GE Healthcare) are prepacked with Ni Sepharose™ which has a high 
protein binding capacity and works on the same principle as the columns used with 
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the AKTAprime-system. They were used to purify protein from small expression 
trails, in order to check if the His-tagged protein was indeed soluble and if it could be 
purified before the large scale purification was attempted. Buffers are accelerated 
through the column by means of centrifugation for 30s at 70 x g. The column was first 
equilibrated with 600µ1 of binding buffer (20rnM sodium phosphate, 500rnM NaCl, 
20rnM imidazole, pH 7.4) after which 600µ1 of the His-tagged protein solution was 
loaded. Non-specific binding proteins were washed through with 600µ1 binding buffer 
and the protein was eluted with 200µ1 elution buffer (20rnM sodium phosphate, 
500mM NaCl, 20mM imidazole, pH 7.4). The different fractions (flow through, wash 
and elution) were analyzed on a 12% SDS-PAGE gel. 
2.5.5.5 Emu/gen 
Cell debri pellets were re-suspended in 3ml O.lM Na2S04 and to this different 
amounts of mulgen® was added to achieve final concentrations of 1-2.5% M/v. 
Thereafter 3ml of a 0.05M Na2S04, IM NaCl and 10% glycerol solution was added 
and the mixture was allowed to tir for 4h. The cell debris was centrifuged, separated 
and the soluble fraction analyzed on a J 2% SDS-PAGE gel. 
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Chapter 3 
Detection and quantitation of the mycothiol pathway 
intermediates 
3.1 Introduction 
As discussed in Chapter 1, one of the major functions of mycothiol (MSH) is 
maintaining the intracellular redox homeostasis, a function which is homologous to 
that of glutathione. A variety of analytical methods, including mass spectrometry, 
have been used to determine the amount of glutathione present in cells (J) . By 
monitoring the depletion of glutathione in cells, the level of oxidative stress that cells 
are under can be determined (2). Thus, glutathione acts as a biomarker for 
determining the oxidative tress inside eukaryotic cells. In the same way MSH can 
also be used as a biomarker for oxidative stress. A change in the ratio of reduced 
MSll and oxidized mycothiol disulfide (MSSM) in cells can be used to determine the 
effect, if any, existing and newly-developed drug may have on M tuberculosis cells. 
urrent methods for determining MSH, MSSM and other mycothiol pathway 
intermediates most commonly utilize high pressure liquid chromatography (HPLC) 
and require the derivatisation of the e molecules (3, 4) . Two derivatisation methods 
often used in mycothiol pathway studies are monobromobimane and AccQ-Fluor 
(Water orp.) (3-6) . Monobromobimane is used to derivatise the free thiol of MSH 
and AccQ-Fluor the free amine of aGlcN-Ins (Figure 3.1). MSSM levels can also be 
determined through monobromobimane derivatisation, but has to be preceded by the 
reduction of the molecule's disulfide to its free thiol form (7). With both of these 
method a fluorogenic product is formed which is visualized using UV-HPLC. 
Stellenbosch University  https://scholar.sun.ac.za
Chapter 3: Detection and quantitation of the mycothiol pathway intermediates 
MSll Monobromobi mone 
1\ctQ-l luor 
Figure 3. 1: Derivatisation methods for MSH and aGlcN-Ins producing the fluorogenic products. 
In this chapter we report the development of a new HPLC-ESI/MS(TOF) method for 
the simultaneou detection and quantitation of MSH, MSSM and other mycothiol 
pathway intermediates in M smegmatis cell lysate without the need for any 
derivatisation. 
3.2 Method Development 
3.2.1 Analyte extraction methods 
During development of our detection and quantitation method three established 
analyte extraction methods were compared with each other. Two of these methods use 
sonication as mean of cell wall disruption, but differ in the extraction buffer used 
during sonication. In the first method the extraction buffer consists of 0.5% formic 
acid in 80% Me01-VH20 (Buffer A) and was used in the extraction of nitrogen 
containing metabolites from S. enterica (8). The other was used in the extraction of 
MSH from M smegmatis cells; in this case the buffer consisted of 0.25M perchloric 
acid and 2mM EDTA in a 40% MeCN/H20 (Buffer B) (9). In the third analyte 
extraction method a commercially available protein extraction reagent, BugBuster® 
(Novagen), was used. BugBuster® reagent was originally designed to disrupt E. coli 
cell walls without the need for sonication. Using it for the disruption of the more rigid 
M smegmatis cell walls would therefore constitute a new application for this reagent. 
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After evaluation of the three extraction methods, analyte extraction with BugBuster® 
was proven to be the best of the three methods. In comparison with the other two 
extraction methods, the BugBuster® method was by far the fastest and most 
convenient method with which large sets of samples could easily be processed. 
Although the sample preparation time was 2h, all the samples of a set could be 
processed simultaneously, which also minimizes the potential handling errors. The 
BugBuster extraction method also produced better results than that of the other two 
methods as based on analysis of the total ion chromatograms (data not shown). Buffer 
B produced the worst matrix interference, of the three methods, while the main 
problem with buffer A was that after sonication and the removal of the cell debris by 
centrifugation the majority of the methanol had to be removed in vacuo before it 
could be lyophilized. This mean that the amples extracted by this method was 
handled more than in the other two extraction methods. 
3.2.2 LCMS analysis 
The oluble M smegmatis fractions containing the analytes were extracted u ing the 
BugBustcr meth d. Samples were analyzed with a gradient elution program utilizing 
a ynergy 4 µM Fusion RP, 250x2mm column (Phenomenex) on an ACQUlTY 
UPL ® ystem (Waters Corp.). The total analysis time was 20 min. Detection was 
performed with a QT F Ultima API quadrupole mass spectrometer (Micromass, 
Manchester, UK) and the data proces ed with Ma Lynx™ oftware (Microma , 
Manchester, UK). The three analyte of interc t were MSH, MSSM and aGlcN-Ins. 
The ma s pectra were acquired by l/MS(TOF) in the mlz range of 10 1000 amu 
during the whole chromatographic run. Three-dimensional (time, m/z, and inten ity) 
chromatograms were obtained and were extracted for the exact m/z values 
corresponding to the [M+Hf species of each analyte. The extracted ion 
chromatogram responses were measured as area under the curve (AUC) and were 
correlated to analyte tandard of known concentrations. 
The concentration of the MSH standard wa determined using a standard curve 
derived from a DTNB a ay with a range of different glutathione (GSH) standards. 
This MSH standard wa diluted and two different injection volumes were analyzed 
with the HPLC- SVMS(TOF) method. The responses obtained from these two 
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different MSH standards showed a linear response with respect to each other. This 
response factors were used to determine the amount of MSH present in stationary 
phase M smegmatis cells. 
3.2.2.1 aGlcN-Jns identification 
To identify aGlcN-Ins in analyte samples the ion chromatograms were extracted for 
the 342 mlz ion (the mass of the aGlcN-Ins [M+Hr ion). The extracted total ion 
chromatogram for the aGlcN-Ins standard (synthesized via published procedure, 
Jardine et al. (JO)) is shown below (Figure 3.2), along with its corresponding MS 
spectrum (Figure 3.3). The MS spectrum clearly shows the [M+Hr, [M+Nar and the 
[M+H]2+ ions of the standard. Similarly, the MS spectrum of the corresponding 
analyte sample clearly shows the same [M+Hr value of the natural occurring aGlcN-
lns in the M smegma/is extraction (Figure 3.4). aGlcN-Ins had a similar retention 
time of - 2.9min in both amples. An MS/MS experiment (data not shown) was also 
performed to show that in future, a selective ion monitoring (SIR) method could also 
be utilized for the identification and quantitation of aGlcN-Ins. 
100 
0 
0 
0 
2.00 
2.90 
I 
> 
4.00 6.00 8.00 
10 1 I\ 
-12 
rime 
10.00 
Figure 3.2: GlcN-lns standard ion chromatogram extracted for the m/z 342 [M+H]+ ion of nGlc-
lns. 
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Figure 3.3: MS spectrum of the aGlcN-lns standard. 
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Figure 3.4: The total ion chromatogram of the M. smegma/is cell ly ate extracted for the mlz 342 (M+Ht 
value of aGlcN-lns. 
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Figure 3.5: MS spectrum corresponding to the total ion chromatogram of the M smegmatis cell lysate 
extracted for the mlz 342[M+I1r ion of aGJcN-lns. 
3.2.2.2 Mycothiol (MSH) identification 
To identify mycothiol the total ion chromatogram of a standard sample was extracted 
for the m/z 487 [M+Hr ion of MSII. The chromatogram and its corresponding MS 
spectrum is shown in Figures 3.6 and 3.7 respectively. The MS spectrum clearly 
hows the [M+Ilr and [M+Nat values of the MSH standard. MSH had a retention 
time o[ 4.4mins in the total ion chromatogram of the M smegmatis lysate extracted 
for m/z 487 [M+Ht The corresponding MS spectra also shows the [M+Ht and 
[M+Na] 1 ions of MSII (Figure 3.9). 
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Figure 3.6: MSH standard ion chromatogram extracted for the m/z 487 [M+Hr ion of MSH. 
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Figure 3.7: MS spectrum of the MSH standard 
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Figure 3.8: The total ion chromatogram of the M smegmatis cell lysate extracted for the m/z 487 [M+Ht 
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Figure 3.9: M spectrum corresponding to the total ion chromatogram of the M smegma/is cell lysate 
extracted for the m/z 487 [M +I If ion MSH. 
3.2.2.3 Mycothiol disulfide (MSSM) identification 
Mycothiol disulfide could be identified by extracting the total ion chromatogram for 
the m/z 971 [M+Ht ion of MSSM. The chromatogram for the MSSM standard is 
shown in Figure 3.10, and its corresponding MS spectrum in Figure 3.11. The MS 
spectrum shows the [M+Ht ion and the weak [M+Nat ion of the standard. Similar 
results were obtained when M smegmatis lysate was analyzed, although the peak 
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obtained by extracting the total ion chromatogram for the m/z 971 [M+Ht ion had a 
slightly delayed retention time compared to that of the standard (Figure 3.12). The 
corresponding MS spectrum (Figure 3.13) also shows the [M+Ht ion and a weak 
[M+Nat ion of MSSM. 
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Figure 3.10: MSSM standard ion chromatogram extracted for the mlz 97 I [M+Ht ion of MSSM. 
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Figure 3.11: MS spectrum of the MSSM standard. 
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Figure 3.13: M spectrum corresponding to the total ion chromatogram of the M smegmatis cell lysate 
extracted for the m/z 97 1 [M+Ht ion of MSSM . 
3.2.3 Induction of oxidative stress 
In a study performed by Ung et al., cellular stress were invoked in M bovis BCG cells 
with the addition of diamide or hydrogen peroxide (H20 2) to stationery phase cultures. 
Both diarnide and H20 2 induced oxidative stress inside cells. Diarnide or N,N,N',N'-
tetramethylazodicarboxarnide penetrates the cell and causes specific oxidation of 
intracellular low molecular weight thiols to their disulfide forms. This form of 
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oxidative stress is called disulfide stress and leads to the buildup of foreign disulfide 
bonds in the cytoplasm (I 1). The authors monitored the MSH and MSSM levels after 
oxidative stress was induced and reported depletion of the MSH and a change in the 
basal MSH:MSSM levels. These authors used the monobromobimane derivatisation 
and HPLC detection method mentioned in section 3.1 for the quantitation of MSH and 
MSSM. 
To test if our LCMS method could be used to detect differences in the MSH:MSSM 
ratios under different cell growth conditions, the experiments of Ung et al. were 
repeated by inducing oxidative stress in stationary phase M smegmatis cultures. 
Cultures at stationary phase provides a more accurate representation of the MSH and 
MSSM levels inside the cell, as it eliminates the effect of oxidative stress caused by 
cellular re piration. 
3.2. 3.1 Analyte extraction done with all three methods 
In an attempt to reproduce the results obtained by Ung et al., all three extraction 
methods were used. For each of the onication methods (with buffers A and B) a set 
of 4x300ml M smegmatis cultures were grown until stationary phase. In two of the 
cultures oxidative strcs wa not induced (blank culture ) and diamide or H20 2 was 
added to the remaining two cultures in a final concentration of 5mM and lOmM 
respectively. At each time point (0, 1, 4 and 8h) after oxidative stress was induced, a 
50ml sample of each of the four cultures were taken. Cells were collected through 
centrifugation and stored at -20° until the extractions were performed. 
For the BugBuster® method, fifteen l.5ml M smegmatis cultures, in 2rnl Lidsac® 
tube ( ppendort), were grown until it reached stationary phase. Oxidative stress was 
induced by the addition of diamide to five tubes and H20 2 to another five of the tubes. 
Nothing was added to the remaining five tubes (blank cultures) . At the previously 
mentioned time points three tubes were removed, one for the blank culture and one of 
each stress-induced culture (as induced by addition of either diamide or H202). The 
cells were al o collected and stored until extractions could be done. 
Two major shortcomings were discovered with this method. The first is that more 
than half the culture medium evaporated from the l .5ml culture tubes intended for the 
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BugBuster® extraction. This was proof that the Lidsac® tubes and membrane lids 
designed for the growth of E. coli is not suitable for the long incubation periods 
required for M. smegmatis culturing. Thus, the data obtained from these extractions 
were not representative of the oxidative stress the cells were experiencing. The second 
shortcoming with this method is the length of time it took to extract fifteen samples 
using the sonication methods. Thus, the latter methods were not well suited for 
development into a high-throughput quantitation of MSH:MSSM under various cell 
growth conditions. The BugBuster® extraction method was in many aspects better 
suited for the task. 
3.2.3.2 Analyte extraction with the BugBuster® method 
As was seen above (sections 3.2.l and 3.2.3.1) the BugBuster® extraction method is 
better suited for the processing of large sets of samples and the Ung et al. experiment 
was repeated, thi time only using the BugBuster® method for analyte extraction. It 
was also decided to induce oxidative stress in only one M. smegmatis culture using 
1 Ii02. The reason for choosing H20 2 i twofold. First, in the Ung et al. experiment 
larger differences in M H and MSSM levels were ob erved in the presence of H20 2. 
Second, H20 2 is a reactive oxygen specie that is released during the "oxidative burst" 
inside macrophage phagosomes as a natural defense against a M. tuberculosis 
infection. 
Two M. smegmatis culture (300ml) were grown until they reached stationary pha e, 
after which H20 2 (final concentration of lOmM) was added to one of the two cultures. 
The other culture erved as the control. At 0, 1 and 6h after oxidative stress was 
induced, three aliquots of 15ml each were taken from each of the two cultures. The 
cells were collected by centrifugation, washed and stored at -20°C until further use. 
After all the samples were collected extraction was performed with the BugBuster® 
method as described above and submitted for LCMS analysis. 
At the Oh time point all the MSH and MSSM levels are similar (Figure 3.14). This is 
expected, ince the cells are in stationary phase and the amount of oxidative stress 
they are subjected to should be similar and would be reflected in their MSH and 
MSSM levels. However, analysi of cultures removed at the lh time point shows that 
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dramatic changes in the MSH and MSSM levels have taken place in the cells to which 
H202 was added. An even bigger change was observed at the 6h point. This is a 
consequence of the induced oxidative stress the cells were experiencing. This is in 
contrast to the MSH and MSSM levels of the blank samples analyzed at the lh point, 
which were still similar to their original values, although there was a slight elevation 
in the amount of MSH. There was a big change in the MSH and MSSM levels of the 
blank sample at the 6h point. This seems to indicate that even cells in the blank 
samples start to experience oxidative stress without the addition of any oxidative 
agents. 
1600 
1400 
1200 
1000 
u 
::::> 
< 800 
600 
400 
200 
0 
T=Oh T- th T=6h 
Figure 3. 14: Bar graph depicting the changes in MSH and MSSM levels over time. 
3.3 Conclusion 
• Blank M H 
•Blank M SM 
• H20 2 MSll 
a H20 2 M SM 
A new method for the simultaneous detection and quantitation of MSH and MSSM 
has been developed. With this method there is no need for the derivatisation of these 
two analytes. It is shown that this method can be used not only to determine the MSH 
and MSSM levels inside M smegmatis, but also to detect aGlcN-Ins, an intermediate 
in the biosynthesis of MSH. The results of the HPLC-ESl/MS(TOF) method show 
that it is capable of resolving the three analytes in the same run with aGlcN-lns, MSH 
and MSSM having retention times of 2.9, 4.4 and 5.3min respectively. Also the 
commercially available BugBuster® protein extraction reagent was used in a new 
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application and with great success. All the analytes could be detected usmg 
BugBuster® extractions, which demonstrated a great improvement on prior extraction 
methods. 
The calculated amount of MSH present in the Oh time point stationary phase cells was 
a factor of ten more than that previously reported by Ung et al. (7) and Newton et al. 
(3). A full analytical evaluation of this quantitation method is currently in progress, 
but the preliminary results indicate superior sensitivity of this LCMS-based method 
over the established protocols. 
3.4 Experimental 
3.4.1 Culturing 
The M smegmatis ATCC 19420 cell stock wa a gift from Prof. Daan Steenkamp, 
Medical School, University of Cape Town. All M smegmatis culturing and 
experiments were done in Middlebrook 7H9 Broth (Difeo) to which 5% glycerol and 
0.05% Tween 80 ( igma) was added. No antibiotic were u ed. Before every 
experiment an "overnight" M smegmati culture wa grown for 24b at 37°C. This 
culture was u ed to inoculate the experimental culture media. The inoculated cultures 
were incubated for 35h at 37°C. This gave the cell enough time to reach the 
stationery phase, as all experiments were performed at stationary pha e M smegmatis 
cultures. After incubation the cells were collected through centrifugation for 30rnin at 
4500rpm. The re ulting cell pellet were processed accordingly. 
3.4.2 Extraction methods 
3.4.2.J Sonication with buffer A 
This method was used to extract nitrogen contairung metabolites from Salmonella 
enterica ( 8). The cell pellet wa resu pended in 80% Me0H/H20 solution containing 
0.5% formic acid followed by di ruption by sonication. After sorucation the cell 
debris wa removed by centrifugation, the methanol was evaporated in vacuo and the 
remainder of the aqueous supernatant was lyophilized overnight. The re ulting residue 
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was reconstituted in lml 50% MeCN/H20, spun through a NANOSEP 3K OMEGA 
size exclusion centrifugal column (Pall) and submitted for LCMS analysis. 
3.4.2.2 Sonication with buffer B 
Steenkamp et al. (9) used this method to purify mycothiol from M smegmatis. In this 
method the cells were also disrupted through sonication, but the extraction buffer used 
consisted of 0.25M perchloric acid and 2mM EDTA in a 40% MeCN/H20. After the 
cell debris was removed the supernatant was directly lyophilized overnight. The 
resulting residue was processed as mentioned above before LCMS analysis. 
3.4.2.3 BugBuster® extraction method 
BugBuster® protein extraction reagent (Novagen) was also used to extract the 
analyte . Cell pellets were resuspended in five times less extraction buffer than the 
culture sample the cell were pelleted from. The u pensions were incubated for 40min 
at room temperature on a shaking platform. The cell debri was removed through 
centrifugation and the upematant lyophilized overnight. The remaining re idue was 
rcdis olved in 50% MeCN/1120 and processed as mentioned above. 
3.4.3 LCMS analysis 
Samples were analyzed on an ACQUITY UPLC system (Waters Corp.) with an 
autosampler and a Synergy 4 µM Fusion RP, 250x2mm column (Phenomenex). The 
sample injection volume was 20µ1 and the auto sampler syringe wa wa hed with 
so lvent A (0.1 % formic acid in water) before each injection. A gradient elution 
program with a flow-rate of 0.20 ml/min was used for the analy is. The gradient was 
as follows: 100% solvent A for 8 min; 7 min linear increase up to 95% solvent B 
(0.1 % formic acid in acetonitrile); 95% B step for 3 min; 95% solvent A from 18 to 
20 min. The Lota! analysis time was 20 min. 
Detection was performed on a QTOF Ultima API quadrupole mass spectrometer 
(Micromass, Manchester, UK). Analyte were detected in the positive ion mode. The 
capillary voltage was set at 3500 V. The source temperature and the nebulization gas 
temperature were el at 120 °C and 400 °C, respectively. The cone voltages were set at 
35V. Data was proces ed using MassLynx™ software (Micromass, Manchester, UK). 
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3.4.4 Induction of oxidative stress 
3.4.4.1 Analyte extraction done with all three extraction methods 
M smegmatis stock (260µ1) was used to inoculate 13ml of 7H9 media and incubated 
for 24h at 37°C. This culture was used to inoculate the four 300ml and fifteen 1.5ml 
(in 2ml Eppendorf LidsAc® tubes) cultures used in the experiment. A 50ml sample 
was taken out of each of the four 300ml cultures before H20 2 (final concentration of 
l OmM) was added to one culture and diamide (final concentration of 5mM) to 
another, in order to induce oxidative stress. Nothing was added to the other two 300ml 
cultures, as they were used as blanks. The samples taken before the diamide and H202 
was added, was used as the Oh time point samples. Samples (50ml) were also taken at 
the l, 2, 4 and 8h time points. Cells from these samples were collected by means of 
centrifugation and pellets were stored at -20°C until processing. 
ln the ca e of the I .5ml cu ltures, samples were not taken, as the whole sample was 
used . Thus at the Oh time point, four of the l.5ml cultures were removed and cells 
collected through centrifugation. Diamide was added to four samples and H20 2 to the 
other four of the remaining l .5ml culture , resulting in final concentration of 5mM 
and lOmM respectively. At each of the other time points, an additional four cultures 
were removed, one to which diamide was added, one to which l-h02 wa added and 
two to which nothing wa added. Each time the cells were cetrifuged and stored at -
20° until required . 
Each of the pellets obtained from the 50ml amples were divided into two pellets with 
equal ma s, resulting in a total of 24 pellets. Sonication with buffer A was u ed to 
proces 12 of the pellets and the remaining 12 was processed using onication with 
buffer B. The cell pellets from the 1.5ml cultures were extracted with the BugBuster® 
method, but the resuspended cells were incubated for 120min instead of the 40min. 
3.4.4.2 Analyte extraction with the BugBuster® method 
Two 300rnl stationary phase M smegmatis culture were prepared as described above. 
Three Oh time point samples (15ml each) were taken from each culture before the 
addition of H20 2. H20 2 was added to one of the cultures to a final concentration of 
58 
Stellenbosch University  https://scholar.sun.ac.za
Chapter 3: Detection and quantitation of the mycothiol pathway intermediates 
lOmM. The other culture was used as control and nothing was added to it. Another 
3x15ml samples were taken from each culture at the lh and 6h time points. Cells were 
collected through centrifugation and stored at -20°C until required. Extractions were 
performed by resuspending the cells in lml of BugBuster® protein extraction reagent 
followed by incubation for 120 min at room temperature on a shaking platform. Cell 
debris was removed by centrifugation and the supernatant lyophilized overnight. The 
resulting residue was reconstituted in 250µ1 50% MeCN/H20, spun through a 
NANOSEP 3K OMEGA centrifugal column (Pall) and submitted for LCMS analysis. 
3.4.5 Statistical Data Analysis 
All statistical data analysis and graphical presentation of the data was performed with 
Microsoft® Office Excel 2003. 
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Alternate substrates of MshB and Mtr 
4.1 Introduction 
As discussed in Chapter 1, mycothiol (MSH) has a very unique structure, which in the 
past has inspired the synthesis of analogues of the parent structure and of its 
biosynthetic pathway intermediates (Figure 4.1 ). 
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Figure 4.1: Key substrate analogues of mycothiol and its pathway intermediates. 
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The first reported MSH analogue was a cyclohexyl thioglycoside obtained by Knapp 
et al. through the free radical reaction of 2-acetarnido-2-deoxy-3,4,6-tri-O-acetyl-1-a-
thio-D-glucopyranose ( aGlcNAc-mercaptan) with cyclohexene (Figure 4.1, A2)(J). 
The advantage of thioglycosides is that generally they are kinetically more stable than /~ 
oxygen glycosides with respect to enzymatic hydrolysis by glycosidases (2). This 
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means that inside a cell thioglycosides are not hydrolyzed easily, increasing the 
chance of the thioglycoside reaching its intended target. The cyclohexyl thioglycoside 
was later used as a scaffold in the synthesis of a library of 36 substrate analogues for 
mycothiol-S-conjugate amidase (Mca) (3). The compounds in the library differed 
from one another by the moieties bound to the free amine through an amide bond. 
Metaferia et al. used a natural product inspired pseudo-disaccharide scaffold to synthesize 
a series of inhibitors of MshB. These inhibitors again differed from one another by the 
moieties bound to the free amine. The inhibitors that showed the best inhibition had 
the moieties B3a-c (Figure 4.1 ), which were all derived from natural products ( 4). 
Newton et al. showed that the natural glucosamine-inositol disaccharide connected to 
a monobromobinane (mB) derivati ed cysteine (Figure 4.1, B2) through a peptide 
bond with the glucosamine amine, is a better substrate for MshB than its natural 
substrate a.GlcNAc-lns. The reasons for this increased activity are still unknown. Also 
a.GlcNAc, with no moietie bound to the anomeric oxygen (Figure 4.1, Al ), is a 100 
times les active with M hB than a.GlcNAc-lns (5). 
A library of substrate mimicking inhibitors was also synthesized and tested again t 
Mca (6). The authors used a quinic acid (Figure 4.1, A3) containing scaffold, with an 
0 -glycosidic bond, as the basis for their inhibitor library . The two compounds that 
showed the best inhibition were derivatised with substituents Bla and Blb (Figure 
4.1) on the glucosamine amine. 
Thus, as was proven in the discu sion above, the a.GlcNAc or a.GlcNAc-rnereaptan 
moieties proved to be u eful core synthons for the design of ubstrate analogues for 
MSH and its pathway intennediates . In thi chapter we report on the alternate 
substrates for MshB and Mtr that was synthesized during tbi study. 
4.2 Synthesis of key alternate substrate intermediates 
The basic intermediates used in the synthesis of all the thioglycosides alternate 
substrates for MshB during this study is 2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-l-a-
thio-D-glucopyranose (a.GlcNAc mercaptan) (4.7). Compound 4.7 was synthesized 
through the route depicted in Scheme 4.1, which is well characterised in previous 
glycosidic studies (7-9) . 1,3,4,6-Tetra-O-acetyl-glucosamine hydrochloride (4.4), an 
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intermediate in the synthesis of compound 4.7, was also used in the synthesis of des-
myo-inositol mycothiol disulfide (DI-MSSM) 
1,3,4,6-Tetra-0-acetyl-glucosamine hydrochloride ( 4.4) was synthesized from the 
commercially available D-glucosamine hydrochloride (4.1) as described by Myszka et 
al. (7). 1,3 ,4 , 6-Tetra-0-acetyl-2-deoxy-2-acetamido-~-D-glucopyranose (~-D­
GlcNAc) (4.5) was prepared by the reaction of 1,3,4,6-tetra-0-acetyl-glucosamine 
hydrochloride (4.4) with pyridine and acetic anhydride. The ~-D-GlcNAc (4.5) was 
reacted with Lawesson's reagent to produce the GlcNAc-thiazoline (4.6). The 
thiazoline ring of GlcNAc-thiazoline (4.6) was hydrolyzed to produce aGlcNAc 
mercaptan ( 4. 7). Both the synthesis and the hydrolysis of the thiazoline ring was 
previou ly de cribed by Knapp et al. (8, 9). 
,.-OH 
HO~ ·- O 
~tO~OH 
NH,HCI 
4.1 
.J.7 
f 
·--
0 
OAc 
N 
b CH 
? c 
OCH, 
-1 .3 
OAG OAc d / 
AcO'°'\ - - -\ C AcO ' · -\.:~ · vO / 
AcO ~ · -- Ac()~ OAc 
N S ..tNH 
'( '~o 
NH2HCI 
4.4 
CH, 
4.6 4.5 
Scheme 4.1 : Reagents and conditions: (a) aq lM NaOH, p-CH30 - 6Hr HO; (b) Py, Ac20 ; (c) acetone 
SM II I; (d) Py Ac20; (e) Lawesson's reagent, toluene, 80° ; (f) TFA, wet MeOH 
4.3 Thioglycosides 
4.3.1 Thioglycoside disaccharides 
A discussed previously, the largest part of the MSH molecule is the glucosarnine-
inositol disaccharide moiety. Thi disaccharide moiety is the recognition site used by 
enzymes in the binding of MSH and its intermediates. We were interested in the 
binding specificity of MshB to various disaccharide scaffolds, differing in particular 
at the inositol or cyclohexane moiety. Thus, during this study a series of thioglycoside 
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disaccharides scaffolds were synthesized. These thioglycoside disaccharide scaffolds 
will serve as starting points for synthesis of inhibitor or substrate analogue libraries 
targeted against MshB and other MSH binding enzymes. 
The aGlcNAc mercaptan (4.7) was reacted with the 0-acetylated sugars (Table 4.1, 
4.8 and 4.9) in the presence of boron trifluoride etherate-complex (BF30Eti) (see 
Scheme 4.2). The anomeric acetate on the monosaccharide moieties was eliminated in 
the process, to form the oxonium intermediate. Addition of the thiol nucleophile 
occurs from either side of the plane of the electrophilic anomeric centre, giving rise to 
the formation of a- and P-coupled 0-acetylated products 4.lla and 4.12a respectively 
(Table 4.1). 
~~ 
~NHSH 
OAc 
0 (AC0)3~ 
OAc 
4.7 ° 
+ 
or 
l · 
b 
or 
0 (AcO}i-~OAc 
o~onium intcnncdiatc 
Scheme 4.2: General reaction for the synthesis of the thioglycoside disaccharide 
molecules. 
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The deacetylation of these compounds was performed with sodium metboxide in 
MeOH, resulting in the formation of deacetylated compounds, 4.llb and 4.12b (Table 
4.1 ). The a/~ anomeric proton ratios ranged from 1: 1 to 1 :2 as detennined by the 
# The ynthesi of 4.13a,b is currently in progre sand no analytical data is available this time. 
4.3.2 Fluorogenic substrates 
As discussed in Chapter 3, current methods for the quantitation of MshB mediated N-
deacetylatcd compound all require the derivatisation of the free amine followed by 
llPLC-UV analysi . This limits the screening throughput of potential alternate 
substrate or inhibitors of MshB. However, to address this shortcoming a fluorescent 
binding a say was developed in a previou tudy for the evaluation of inhibitors 
against the M hB homologue Mca. In these a ays MSH was derivatised with 
monobromobimane (MSmB) (Km of 500±50µM) (5) and used as a competitive 
binding molecule with the possible inhibitors (10). The amount of cysteine-bimane 
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released was monitored by HPLC-UV and was a measure of the inhibitor's binding 
affinity to Mca. 
During this study we synthesized a series of fluorogenic thioglycoside molecules as 
potential alternate substrates of MshB. These molecules could be used in competitive 
binding assay , where they serve as fluorogenic substrates by which the binding of 
possible inhibitors could be quantified. Since these molecules are UV active, 
differences in the UV or fluorescence spectra of their enzyme-mediated products 
could be used in the development of a high-throughput MshB assay 
These substrate were synthesized through the triethylamine-mediated alkylation 
reactions of the free thiol of 2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-1-a-thio-D-
glucopyranose (4.7) and various UV active aryl- or alkyl halides ( Table 4.2, 4.14-
4.17) (Scheme 4.3). 
+ R- X :N(Et)3 + (Et)3NHX 
chcme 4.3: General reaction for lhe ynlhesi of the nuorogcnic substrates. 
The alkylation reaction resulted in the formation of thioglycoside compounds 4.18a, 
4.J9a, 4.20a and 4.21a respectively (Table 4.2). The 0-deacetylation of 4.18a-4.20a 
was performed with Amberlite IRA400 (OII) re in in a 19% H20, 50% MeOH and 
31 % acetone mixture (11), to produce 4.18b-4.20b. Thi mild deprotection was used 
becau e of the difficultie experienced with other deprotection method . For example, 
in the deprotection of 4.19a in particular it wa found that the S-aryl/alkyl bond was 
easily cleaved if a strong base uch as odium methoxide had to be used. The coupling 
constants of the anomcric proton are noted in Table 4.2 and are all con istent with an 
a-coupled thioglyco ide. 
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Table 4.2: Fluorogenic substrates 
Alkyl/a rylhalide Product o (ppm) Hz 
~ RO F'O R I ~ N02 NHsO 6.1 5.36 ,o I~ 
~ N02 
4. 14 4. 18a,b 
~ Fo RO R N02 I ~ N02 
-<"sO 6.1 5.44 
~ N02 
4. 15 4. 19a,b 
"'~7i RO ~NHs{Ni ~ N ;) 5.5 5.51 0 ~ ;) 
4.16 
Br 
u ,NH5 # # Ou I~ 
4.17 4.2 1a,b 
Ra = Ac 
Rn = II 
# The NMR characterization of 4. 1 Sb, 4.20b and 4.2 l a is currently in progress, after which the 
deacetylation of 4.2 1 a will be attempted. 
4.4 Des-myo-inositol mycothiol disulfide 
The synthesis of 2(N-acety l-L-cysteinyl)-amino-2-deoxy-( a/~)-D-glucopyranoside 
(also known a des-myo-insitol mycothiol disulfide, DI-MSSM) was previously 
reported by Patel and Blanchard (I 2). This molecule is a truncated form of mycothiol 
as it lacks the inositol moiety. The authors used DI-MSSM as a substrate analogue 
(Km of 510±40µM) for all subsequent kinetic studies of the Mtr enzyme (I 3, 14). /,.,.. 
68 
Stellenbosch University  https://scholar.sun.ac.za
Chapter 4: Alternate substrates ofMshB and Mtr 
Since DI-MSSM is a Jess expensive alternative to synthetic MSH, we also set out to 
prepare this compound as a substrate with which the activity of the E. coli expressed 
Mtr enzyme could be tested. During this study DI-MSSM was synthesized by a 
different synthetic route than the one previously described. 
The synthesis proceeded by the formation of amide bonds between (Boc-Cys-OH)2 
(4.22) and two equivalents of the protected glucosamine (4.4), to produce the disulfide 
compound ( 4.23). Thi was accomplished by an EDC coupling reaction (Scheme 4.4, 
route a). The acid catalyzed deprotection (Scheme 4.4, route b) of the cysteine a-
amino Boe protecting group resulted in the formation of the free amine compound 
(4.24). Subsequent N-acetylation of compound (4.25) was achieved by the reaction of 
the free amine with an acetic anhydride-pyridine mixture (Scheme 4.4, route c). 
Deprotection of compound ( 4.25) with magnesium methoxide in methanol, followed 
by treatment with Dowex-50W, successfully gave the 0-deacetylated compound, DI-
MSSM (4.26). The structure of 4.26 was confmned by 1H and 13C NMR spectra and 
correlates to that reported in the literature (I 2). 
AcO 0 "'+" 
/, NH.ll_ ~ v 0 ~AcO y- 11 O  
~o 
o S OAc 
OAc O)l~ HN ...- 0 
+-- O OAc 
..... 4.22 UJ 
b 
AcO 
NH 
NH1 
s 
s 
NH2 
/ 
OAc 
4.26 
Scheme 4.4: Reagent and condition : (a) DIPEA, HOBt, ED ; (b) 50% DCM, TFA; {c) Py 
Ac20; (d) 1. Mg(OMeh, MeOH, 2. Dowex-50W (HJ 
HN 
0 
OAc 
4.2.f 
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4.5 Conclusion 
In a study performed by Newton et al. (5) it was found that there is an structural 
similarity in the types of molecules that effectively bind to Mca and MshB. From this 
finding, the cyclohexyl thioglycoside scaffold used by Knapp et al. (3) in the Mca 
substrate library synthesis was also later used by Metaferia et al. ( 4) in the synthesis 
of a series of inhibitors against MshB. Thus the thioglycoside disaccharides 
synthesized successfully during this study will serve as glycosidase resistant scaffolds 
for substrate libraries against other glycosyl inositol binding enzymes, like Mca and 
not only MshB. 
We also successfully synthesized a series of fluorogenic thioglycosides. These 
molecules are indi pen able toward the development of a high throughput screen for 
MshB. Another advantage of the e molecules is that although the molecules are UV 
active, N-deacetylation, whether enzymatically or chemically mediated, leads to the 
free amine. Thus, further elaboration through the amine group could lead to molecules 
which may di play intere ting inhibition propertie ( 4, 15). 
The truncated analogue or mycothiol, Dl-MSSM, was successfully synthesized by an 
improved method compared to the published synthesis (12). Dl-MSSM' main utility 
lies in it ability to act a a substrate of the Mtr enzyme, and having it available 
allowed us to test the activity or the Mtr enzyme expressed during this tudy. DI-
MSSM can al o be used in the protein cry tallization trails or Mtr, where it may erve 
as a ligand. 
4.6 Experimental 
4. 6.1 General 
hemical were purcha ed from Sigma Aldrich. All reactions were performed at room 
temperature unles specified otherwi e. Flash chromatography wa performed using a 
silica to crude reaction mixture ratio of 20: 1 by weight. Thin layer chromatography 
(TLC) was performed on Merck Aluminium Silica gel 60 F254 plate . All compounds 
containing free amine were vi ualized on TLC plate by praying the plates with 
ninhydrin solution ( 1.5% ninhydrin in n-butanol with 3% AcOH) followed by heating ,..,..--
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the plates until the colour developed. All fluorogenic compounds were visualized on 
the TLC plate under UV light. ESI-MS analysis was performed on a QTOF Ultima 
API quadrupole mass spectrometer. 1H and 13C NMR was performed on the Varian 
Unity lnova 600MHz NMR and Varian VXR 300MHz NMR spectrometers. 
4. 6.2 Synthesis of thioglycoside compounds 
4. 6.2.1 Synthesis of 2-Acetamido-2-deoxy-3,4, 6-tri-0-acetyl-l-a-thio-D-
glucopyranose 
l,3,4,6-tetra-0-acetyl-glucosamine hydrochloride ( 4.4). The same synthetic 
procedure was followed as described by Myszka et al. (7) 
for the preparation of 2-deoxy-2-[p-
methoxybenzylidene(amino )]-D-glucopyranse ( 4.2) . To a 
olution of 0-glucosamine hydrochloride (25g, 0.12mol) 
(4.1) in lM NaOH was added p-anisaldehyde (17ml, 0.14mol). The reaction was 
allowed to stir for 2 hr and refrigerated overnjght. The wrute precipitate was filtered 
off and washed with cold water and a 1: 1 EtOH, t20 mixture. A yield of 65% (2lg) 
was achieved. Lntermediate compound 4.2 (2lg, 0.071mol) was 0-acetylated with 
pyridine (135ml, 113mmol) and acetic anhydride (75ml, 0.9mol) to produce 
compound 4.3 (25g, 75% yield). The latter compound (25g, 54mrnol) wa di solved 
in warm acetone (200ml) to which SM HCl (lOml) was added. The mixture was 
allowed to cool, followed by the addition of 200ml Et20. The mixture was allowed to 
stir [or 2 hrs, followed by refrigeration overnight. The resulting precipitate was 
filtered and washed with t20. A yield of 80% (15g) was achieved. 
l,3,4,6-tetra-O-acetyl-2-deoxy-2-acetamido-(3-D-gluco-pyranose (4.5). Compound 
OAc 4.4 (15g, 32mmol) was reacted with acetic anhydride 
AcO (12ml, 3.5mmol) and pyridine (12ml, 3.5mmol) in lOOml 
A OAc 
NH DCM, a described by Myszka et al. ( 7). The reaction 
, 0 mixture was concentrated and stirred in a 15ml ethyl 
acetate/H20 mixture for 30mins, after which 2ml lM HCl was added. The H20 and 
organic layers was allowed to separate, the ethyl acetate was dried over anhydrous 
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sodium carbonate, followed by the evaporation of the orgamc solvent in vacuo, 
producing 3.22g (26% yield) of compound 4.5. 
(3aR,5R,6R, 7 R, 7 aR)-5-(Acetoxymethyl-6, 7-diacetoxy-2-methyl-5,6, 7, 7 a-tetra-
AcO 
A 
OAc hydro-3aH-pyrano[3,2-d)thiazole (4.6). A solution of 
compound 4.5 (3 .2g, 8.2mmol) in toluene was reacted with 
Lawesson's reagent (2. lg, 5.4mmol) in 30ml toluene. The 
s N~ reaction was heated at 80°C for 1.5 hrs, after which the pH 
cH3 of the reaction was adjusted by the addition of 3g sodium 
bicarbonate (9). Compound 4.6 was purified using flash chromatography 
(30%Et0Ac/DCM) to obtain a yield of 63% (1.8lg) . 
2-Acetamido-2-deoxy-3 ,4, 6-tri-0-acety l-1-a-thio-D-gl ucopyranose (4.7). A 
AcO 
A 
OAc solution of compound 4.6 (lg; 2.9mmol) in lOml MeOH was 
cooled to 0°C, before TF A (300µ1) and H20 (300µ1) was 
NH SH added (9) . The reaction wa allowed to warm to room 
, 0 temperature over a period of 2 hr. Subsequently, the reaction 
mixture was concentrated to obtain a yield of 86% (900mg) of compound 4.7. 1H 
NMR' of 4.6 and 4.7 was performed in CDCl3 and identical spectra to that reported 
by Knapp and Myers (9) was obtained. 
4.6.2.2 Thioglyco ide disaccharides 
J-S-(2-Acetamido-2-deoxy-3,4,6-tri-0-acetyl- a -D-glucopyranosyl}-1-thio-2,3,4,6-
tetra-0-acetyl-a/0 -D-mannopyranoside 
(4.lla). To a solution of compound 4.7 
(500mg, L.37mmol) in lOml DCM, wa added 
a-D-mannose pentaacetate (4.8) (530mg, 
1.37rnmol) and BF30Et2 (500µ1, 4.18mmol) . 
The reaction mixture was allowed to stir at 
ambient temp under an N2 atmosphere for 24hrs. The reaction was then concentrated 
and the resulting crude product was purified using flash chromatography 
(5%Me0H/DCM). Fractions containing the product (4.1 la) were concentrated, 
resulting in a yield of 530mg (55%) of a colourless oil. 
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1-S-(2-Acetamido-2-deoxy-a-D-glucopyranosyl)-1-thio--a/O-D-mannopyranoside 
(4.llb). To a solution of compound 4.lla 
(220mg, 0.317mmol) in 8ml MeOH, was added 
12ml of a 180mM solution of Na0CH3 in 
MeOH. The reaction mixture was allowed to stir 
HO~ 
~:Hs~H 
0 1 OH for 18hrs. The reaction was purified using Cl8 
OH OH flash chromatography (5%Me0H/H20), resulting 
in compound 4.llb a an off white solid, with a yield of 80mg (63%). 
1-S-(2-Acetamido-2-deoxy-3,4,6-tri-O-acetyl- a -D-glucopyranosyl}-l-thio-2,3,4,6-
tetra-0-acetyl-a/6-D-galactopyranoside 
(4.12a). To a solution of compound 4.7 (500mg, 
l.37mmol) in lOml DCM, was added a-D-
galactose pentaacetate (4.9) (530mg, l.37mmol) 
and BF30Et2 (500µ1, 4.18mmol). The reaction 
conditions were the ame as stated in the 
preparation of 4.lla. The reaction mixture wa concentrated and purified using flash 
chromatography (5%Me01-l/D M), resulting in 480mg (50% yield) of a light yellow 
oil (4.12a). 
1-S-(2-Aceta m ido-2-dcoxy-a-D-gl ucopyranosyl)-1-thio--a/6-D-galactopyranoside 
HO~O\ 
HO~ 
NHS ~O~H 
OH OH 
4.6.2.3 Fluorogenic substrates 
(4.J2b). The 0-deacetylation of compound 4.12a 
to produce compound 4.12b was performed as for 
compound 4.llb above. Thus, 300mg 
(0.433mmol) of compound 4.12a was deprotected 
to produce 85mg (49% yield) of a light yellow 
solid. 
4-Nitrophenyl 2-acetamido-2-deoxy-1-thio-3,4,6-tri-0-acetyl-a-D-glucopyranose 
(4.18a). A olution of compound 4.7 (280mg, 0.770mmol) in 5ml DCM was stirred 
under an N2 atmosphere. To this solution was added l-Fluoro-4-nitrobenzene (4.14) ,,._. ... 
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(164µ1, 2.8mmol) and TEA (130µ1, l.15mmol). 
The reaction was allowed to stir for 24 hrs, and 
then concentrated. The product ( 4 .11) was 
purified from the crude reaction mixture using 
flash chromatography (2%MeOH/DCM). 
Fractions containing pure compound were 
collected and the olvent removed in vacuo, resulting in 360mg (96% yield) of 
compound (4.18a) as a yellow solid. 1H NMR (CDCh, 600MHz, 25°C): 8 1.974 (s, 
3H), 2.026 (s, 3H), 2.061 (s, 3H), 2.081 (s, 3H), 4.070 (dd, lH), 4.254 (dd, lH), 4.373 
(m, lU), 4.590 (rn, lH), 5.169 (m, 2H), 5.902 (d, lH), 6.013 (d, lH), 7.560 (d, 2H), 
8.152 (d, 2H); ESI-M (+): mlz 485 [M+Ht, 507 [M+Nat. 
2,4-Dinitrophenyl 2-acetamido-2-deoxy-1-thio-3,4,6-tri-O-acetyl-a-D-
glucopyranose (4.19a). To a solution of 
compound 4.7 (500mg, l.37mmol) in lOrnl 
DCM wa added 1-Fluoro-2,4-dinitrobenzene 
(4.15) (173µ1, 1.37mmol) and TEA (230µ1, 
I .65mmol). The mixture wa allowed to stir 
under a N2 atmosphere ror 24hr . The reaction mixture wa then concentrated and the 
resulting crude product wa purified u ing na h chromatography (2%Me0H/D M). 
Fractions containing the product were concentrated, resulting in 570mg (78% yield) 
of compound (4.19a) a a yellow solid. 11I NMR ( DCh, 300MHz, 25°C): 8 1.935 
(s, 3Il), 1.991 ( , 3H), 2.034 (s, 3H), 2.066 (s, 311), 4.043 (dd, lH), 4.265 (m, 2H), 
4.626 (m, 2II), 5.235 (m 2Il), 6. lOO (d, I II) , 8.045 (d,, lH), 8.406 (dd, lH) 9.026 (d, 
UL); E l-M (+): mlz 530 [M+llt. 
2,4-Dinitrophenyl 2-acctamido-2-deoxy-1-thio-a-D-glucopyranose (4.19b). To a 
HO~O\ 
HO~ON02 
~o I~ 
h- N02 
solution of compound 4.19a (230mg, 
0.434mmol) in 18rnl of H20 (19%), MeOH 
(50%) and acetone (31 %), wa added 2.3g of 
Amberlite 1RA400 (OH). The reaction mixture 
was allowed to stir for lhr at ambient 
temperature. The volatile olvents were removed in vacuo and the residual aqueous 
product mixture was subjected to -18 flash chromatography (50% MeCN/H20). 
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Aqueous fractions containing the compound were collected and dried by 
lyophilization, resulting in 50mg (28% yield) of compound 4.19b. 1H NMR (DMSO-
d6, 300MHz, 25°C): 8 1.829 (s, 3H), 3.264 (m, lH), 3.516 (q, lH), 3.588 (m, 2H), 
3.674 (m, lH), 3.983 (m, 11-I), 4.554 (t, lH), 5.125 (d, lH), 5.272 (d, lH), 6.051 (d, 
lH), 8.150 (d, lH), 8.273 (d, lH), 8.426 (dd, lH), 8.818 (d, lH); ESI-MS(+): m/z 404 
[M+Ht, 426 [M+Nat . 
Bimane 2-a ceta mi do-2-d eoxy-1-thio-3 ,4, 6-tri-0-acety 1-a-D-gl u copy ran ose 
OAc (4.20a). To a solution of compound 4.7 
AcO~ (27mg, 0.074mmol) in 2rnl DCM was added 
kO 0 0 . 
NH ~ =<- of monobromob1mane (24mg, 0.089mmol) 
, 0 s ~ ~ ;/ (4.16) and TEA (12µ1, 0.089mmol). The 
reaction was allowed to stir under a N2 
atmo phere for 24 hrs, followed by the removal of the solvent in vacuo . The resulting 
crude product (4.20a) was purified using flash chromatography (2%Me0H/DCM). 
Fraction containing the compound were collected and the solvent removed in vacuo, 
re ulting in 360mg (96% yield) of compound (4.20a) a a yellow solid. 1H NMR 
(CD 13, 400Mllz, 25° ): 8 l .844 (s, 3H), 1.884 (s, 3H), 1.940 ( , 3H), 2.058 ( , 6H), 
2.092 ( , 3H), 2.379 (s, 3II), 3.729 (q, 2II), 4.095 (m, I H), 4.251 (m, 2H), 4.468 (m, 
lll), 5.038 (t, 111), 5.139 (t, III), 5.667 (d, lH), 5.813 (d, JH); Sl-MS(+): m/z 554 
[M+Hf , 576 [M+Na] '. 
Benzvl 2-acetamido-2-dcoxy-1-thio-3,4,6-tri-O-acetyl-a-D-glucopyranose ( 4.21a). 
To a olution of compound 4.7 (220mg, 0.6lmmol) 
in 2ml DCM, wa added benzylbromide (87µ1 , 
0.732mmol) (4.17) and TEA (170µ1 , l.22mmol). 
The reaction mixture was allowed to stir under a N2 
atmosphere for 24hrs. Subsequently the reaction was 
concentrated and the resulting crude product was 
purified u ing flash chromatography (2%Me0H/DCM). Fraction containing the 
product were concentrated, resulting in l 70mg (62% yield) of pure 4.21a as a off 
white oil. 
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4.6.2.4 Synthesis of DI-MSSM 
2(N-tert-B u ty loxycarbo n yl-L-cys tein yl)-amino-2-d eoxy-1,3 ,4, 6-tetra-0-acety l-B-
AcO 
OAc 
0 H ~ ~N O AcO NH ~ l OAc 
s 
o s') 
OAH/JrN 
J-. N 0 /I"'- OAc 
D-glucopyranoside disulfide (4.23). A 
solution (Boc-Cys-OH)2 (500mg, 1.14mmol) 
( 4.22), 4.4 (960mg, 2.5rnmol), HOBt 
(380mg, 2.8mrnol), 550mg 4A molecular 
sieves and DIPEA (850µ1, 5rnmol) in 12ml 
dry DMF was cooled to 0°C before EDC 
(540mg, 2.8rnmol) was added under a N2 
atmosphere. The reaction mixture was allowed to stir at 0°C for lhr followed by room 
temperature over an 18hr period. The DMF was evaporated in vacuo, followed by the 
addition of 25ml of a 50% ethyl acetate/H20 mixture and the resulting mixture was 
allowed to tir for 30min. The H20 and organic layer were allowed to separate. The 
ethyl acetate was dried over Na2S04, followed by evaporation in vacuo, producing 
l.12g (90% yield) of 4.23 a a white olid. 1H NMR (DMSO- d6, 300MHz, 25°C): 8 
J.364 (s, 18H), 1.901 (s, 6H), 1.963 (s, 61-i), 2.01l(d,12H), 2.831(m,4H), 3.986 (m, 
611), 4.185 (dd, 3H), 4.875 (t, 3H), 5.268 (t, 3H), 5.763 (d, 2H), 7.072 (d, 2H), 7.989 
(d, 2H); 1-M (+): m/z 1099.35 [M+ Ht, 1122 [M+Nat 
2(L-cystcinyl)-amino-2-dcoxy-l,3,4,6-tetra-0-acetyl-B-D-glucopyranoside 
AcO 0 
NH\NH2 
s 
I 
Sl HN 
NH2~ 
0 
AcO 
OAc 
disulfide (4.24). To a solution of 
compound 4.23 (600mg, 0.550mmol) m 
5.5ml DCM at 0°C was added TFA (2.5ml, 
34mmol). The reaction mixture was 
monitored by TLC and concentrated after 
being allowed to stir for 2hrs at 0°C. The 
reaction mixture was evaporated under 
reduced pressure overnight, producing 500mg (85% yield) of compound (4.24) as a 
deep red powder. 1H NMR (DMSO- d6, 300MHz, 25°C): 8 1.984 (m, 24H), 3.019 (m, 
SH), 4.081 (m, l LH), 4.900 (t, 2H), 5.058 (d, lH), 5.217 (t, lH), 5.734 (d, lH), 8.365 
(br s, 4H); ESI-MS (+): m/z 901.19 [M+Ht. 
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2(N-acetyl-L-cystein yl)-amin o-2-d eo xy-1,3 ,4,6-tetra-O-acety l-B-D-
AcO 
0 H 
NHJl'(( 
s 
o s') . 
)lNTIHN 
H 0 
OAc 
glucopyranoside disulfide (4.25). To a 
solution of compound 4.24 (500mg, 
0.555mmol) in 7ml DCM, was added 
pyridine (215µ1, 2mmol) and the reaction 
mixture was cooled to 0°C. Acetic 
anhydride (215µ1, 2mmol) was added drop 
wise and the reaction was allowed to warm 
to room temperature over 18hrs. The reaction mixture was concentrated and stirred in 
a 15ml ethyl acetate/H20 mixture for 30min , after which 2ml lM HCl was added. 
The H20 and organic layers were allowed to separate. The organic layer was dried 
over Na2S04, followed by evaporation in vacuo producing 380mg (69% yield) of 
compound (4.25) as a light yellow powder. 1H NMR (DMSO- d6, 300MHz, 25°C): 8 
1.983 (m, 301-I), 2.847 (m, 2 H), 3.990 (d, 4H), 4.182 (m, 7H), 4.879 (m, 0.6H), 5.009 
(m, 2H), 5.198 (m, 2H), 5.751 (t, lH), 5.937 (d, lH), 8.170 (m, 3H); ESI-MS (+): m/z 
983.29 [M+ur, 1005.29 [M+Nat. 
2(N-acetyl-L-cystcinyl)-amino-2-deoxy-{a/B)-D-2lucopyranoside disulfide (4.26). 
HO 
0 H 
To a solution of 4.25 (200mg, 0.509mmol) 
NHJl'(( HO in 38ml of MeOH was added Mg(OMe)2 in 
Me H (I .9ml of a 6% w/v) and the mixture 
s 
I was allowed to tir for 2hr . The reaction was OS\ OH )lN HN neutralized with Dowex-50W(H+) ton-
H 0 exchange re in (pH wa adjusted to 6.5, 
OH 
monitored with trip ), filtered and the pH 
Me LI removed in vacuo. The residual olvent was dried by overnight under reduced 
pressure, producing 50mg ( 42% yield) of compound (4.26) a a off white powder. 1H 
and 13 NMR performed in D20 and the resulting pectra wa identical to that 
reported in the literature (12). ESI-MS (+): m/z 647.22 [M+H( 
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Enzymology 
5.1 Introduction 
During this study we have purified the enzymes, developed the analytical methods 
and synthesized the substrate analogues critical to the development of the drug 
discovery protocol which is the aim of this study. In this chapter we report how the 
different aspect of this study were employed in the conduction of the enzymatic 
studies. 
5.2 MshB 
MshB i very pecific for its natural sub trate aGlcNAc-lns, which is N-deacetylated 
by the enzyme to give aGlcN-Ins a product(l). Removal of the inositol (Ins) moiety 
of aGlcNAc-lns re ult in a 100-fold decrea e in reactivity compared to the original 
ubstrate. During this study 2,4-dinitrophenyl 2-acetarnido-2-deoxy-l-thio-a-D-
glucopyranose (aGlcNAc-DNP) (Table 4.2, 4.19b) was used as alternative substrate 
for MshB. All enzyme reactions with MshB wa performed in a reaction buffer 
containing 50mM IIEP S and 50mM Na 1 at pH 7.4 (2) . The final concentrations of 
enzyme and ub trate were l.5µg/µl and O.lmM re pectively. 
5.2.1 N-deacetylation of 2,4-Dinitrophenyl 2-Acetamido-2-deoxy-1-
thio-a-D-glucopyranose (aGlcNAc-DNP) 
5.2.1.1 LCMS analysis 
The same MshB mediated N-deacetylation of aGlcNAc-DNP (Figure 5.1) was 
analyzed with the ame HPLC-ESI/MS(TOF) method used in the quatitation of MSH, 
MSSM and aGlcNAc-Ins (Chapter 3). The enzyme reactions were incubated for 30 
minutes at 37°C, after which the reaction was stopped by heat inactivation of the 
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enzyme. The denatured enzyme debris was removed by means of centrifugation and 
the reaction mixtures in the supernatant were submitted for LCMS analysis. Reaction 
mixtures were analyzed with a gradient elution program utilizing a Synergy 4 µM 
Fusion RP, 250x2mm column (Phenomenex) on an ACQUITY UPLC® system 
(Waters Corp.). The total analysis time was 20 min. Detection was performed with a 
QTOF Ultima API quadrupole mass spectrometer (Micromass, Manchester, UK) and 
the data processed with MassLynx™ software (Micromass, Manchester, UK). 
M hB 
Figure 5.1: The MshB mediated N-deacetylation of 2,4-Dinitrophenyl 2-Acetamido-2-deoxy- l-thio-a-D-
glucopyranosc ( 4.19b) to 2,4-Dinitrophenyl 2-amido-2-deoxy- l-thio-a-D-glucopyranose (aGlcN-DNP) 
The total ion chromatogram was extracted for the m/z [M+Ht ions of a.GlcNAc-DNP 
and a.GlcN-DNP, the e being 404 and 362 respectively (Figure 5.2). The two 
compounds elute roughly one minute from each other, with the slightly more 
hydrophilic product (a lcN-DNP) eluting first. The area under curve (AUC) of the 
two ion chromatogram of the substrate and product (Figure 5.2) are within the same 
range. Thi means that after 30 minutes. almost half of the substrate was converted to 
product. The total ion chromatogram of the control reaction (buffer and sub trate) was 
extracted for the m/z 404 (M+I-1] ~ ion of a.GlcNAc-DNP to produce a imilar peak to 
the green peak in Figure 5.2 (data not hown). No peak was obtained when the control 
reaction total ion chromatogram was extracted for the m/z 362 [M+Ht ion of a.GlcN-
DNP. This confirm the N-deacetylation reaction wa indeed catalyzed by M hB. 
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Figure 5.2: The total ion chromatogram of the MshB reaction with aGlcNAc-DNP extracted for the mlz 
404LM-+ 11]" ion of aGlcNAc-DNP (green) and the m/z 362 [M +I If ion of aGlcN-DNP (red). 
The corresponding ma s spectra of aGlcNAc-DNP and aGlcN-DNP are shown in 
(Figure 5.3). The two ma s spectra clearly shows the m/z 404 [M+Ht and 426 
[M+Na] f ions (green) of the aGlcNAc-DNP substrate and the m/z 362 [M+Ht and 
384 [M+Nat ions (red) of the N-deactylated product 
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Figure 5.3: The corresponding MS spectra of aGlcNAc-DNP (green) and aGlcN-DNP (red) in the MshB 
reaction mixture. 
5.2.1.2 HPLC analysis 
During this study a llPL method was developed to vi ualize the MshB reaction with 
a lcNAc-DNP as substrate. The M hB enzyme reaction with a-GlcNAc-DNP was 
stopped at different time points and analyzed on an Agilent 1100 Series HPLC with 
an auto sampler and a diode array detector. The HPLC was fitted with a Synergy 4 
µM Fu ion RP, 250x2mm column (Phenomenex) used in all previous LCMS 
analyzes. The program used was a 30% Me0WH20 i ocratic run of 10 mins. per 
analysis, with a flow rate of 0.350 ml/min. The substrate eluted at 5.7 mins and was 
monitored at 330nm. Standard substrate solutions ranging from OrnM to 0.lrnM was 
used to produce a calibration curve. The standard curve was used to graphically 
vi ualize the depletion of aGlcNAc-DNP over time. The experiment was performed in 
triplicate. The enzyme reactions were stopped at 3, 5, 10, 20, 35, 60, 120 and 240 
minutes, after which the enzyme was denatured and removed by centrifugation, 
followed by sample analysis on the IIPLC. A regression curve was used to visualize 
the depletion of the aGlcNAc-DNP over time (Figure 5.4). 
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Figure 5.4: MshB mediated depletion of the aGJcNAc-DNP concentration over time. 
The rate at which the O. lmM aGlcNAc-DNP was depleted was fairly quick (Figure 
5.4), with almost half of the substrate con urned within the 30mins. This quick 
depletion of substrate was also seen in the L M analyses of the enzyme reaction 
topped after 30mins. (section 5.2. l. l). If these results are compared with the results 
obtained by Newton et al. (2) for the N-deacetylation of aGlcNAc-lns by MshB, then 
MshB is more active with aGlcNAc-DNP than with its natural substrate. Almost 
double the amount of a lcNAc-DNP is N-deacetylated in 30 minute compared to 
aGlcNAc-lns over the same time period. 
The isocratic IIPL method poorly resolved the individual aGlcNAc-DNP substrate 
and aGlcN-DNP product peaks because of the similar polarity of the two compounds. 
The substrate peak obtained at 330nm also did not remain constant, which means that 
if the substrate and product co-eluted, the product does not have an absorption 
maximum at 330nm. Further attempts to resolve the product peak were unsuccessful. 
84 
Stellenbosch University  https://scholar.sun.ac.za
Chapter 5: Enzymology 
In a study preformed by Kondo et al. , the authors examined the intramolecular s-N 
Smiles rearrangement of S-(2, 4-dinitropheny l)cysteine to N-(2,4-
dinitrophenyl)cysteine (3) . This rearrangement was performed by incubating S-(2,4-
dinitrophenyl)cysteine with different organic bases, including imidazole. This same 
type of rearrangement could happen, as proposed below, in the MshB active site after 
the N-deactylation of aGlcNAc-DNP. Since the formation of the free amine was 
confirmed with LCMS analysis (Figure 5.2), it is possible that it could attack the Cl 
carbon of the dinitrophenyl moiety in a nucleophilic substitution to the ring (Figure 
5.5, route a) in the presence of the imidazole side chain of His144 in the MshB active 
site. The spiro-Meisenheimer intermediate (MH) would subsequently be formed, 
which is then deprotonated (Figure 5.5, route b) to form (M-1) . The rearrangement is 
completed by the concomitant breaking of the S-C bond and the protonation of the 
thiolate group (Figure 5.5, route c). 
HO_,____(.H - 0 Ho-r-L-.o 
H0-'-1::::{ 
NHA N02 y a 
HO~ 
~~~ 
N02 N02 
(M ii ) 
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HO-rlH - 0 
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Figure 5.5: Proposed S-.N Smiles rearrangement of aGlcNAc-DNP and derivatisation the free thiol 
product with DNTB 
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This rearrangement would result in the formation of a free thiol product, which could 
be derivatised with Ellman's Reagent (DNTB) (Figure 5.5, route d). If the MshB 
reaction mixture therefore give a positive (absorption at 412nm) result for a DTNB 
assay, it would confirm the formation of the rearrangement product. 
5.2.1.3 Ellman 's Reagent assay 
To test this hypothesis MshB was incubated with aGlcNAc-DNP at 37°C and the 
reaction stopped at 3, 5, 10, 20, 35, 60 and 120mins. The enzyme debris was 
subsequently removed, and the reaction mixtures were transferred to new tubes for 
treatment with Ellman's Reagent (DTNB). DTNB is used to derivatise free thiol 
compounds for visualisation using spectrophotometric methods. After incubation of 
the DTN B reactions the reaction mixtures were transferred to a 96-well plate (Costar). 
The amount of DTNB derivatised compound was visualised with a Thermo 
Varioskan™ microplate reader at 412nm. The reaction progression curve is shown in 
Figure 5.6. 
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Figure 5.6: Progression curve generated by a DTNB assay 
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An increase of DTNB absorption over the time (Figure 5.6) in the MshB reaction with 
aGlcNAc-DNP means that a free thiol is formed following the N-deacetylation. The 
negative control reaction, in which no enzyme is present, did not show any absorption 
at 412nrn. Further studies are currently underway to confirm the formation of the 
rearrangement product. 
5.2.1.4 Inhibition study 
Free tbiols bad been used as part of inhibitors for porcine pancreatic carboxypeptidase 
B (pp-CpB). The free thiol group of these inhibitors chelates the active site Zn2+ ion, 
thereby inactivating the enzyme ( 4). To determine if MshB might by inhibited by the 
free thiol of the rearrangement product, an experiment was performed to test if there 
was a difference in enzyme activity between fresh MshB and MshB that was 
incubated with aGlcNAc-DNP for a period of time. A set of MshB reactions was set 
up and incubated as described in section 5.2. They were stopped at 3, 5, 10, 20, 35, 
60, 120 and 180 minutes and analyzed with the HPLC method developed during this 
study (Figure 5.7, curve A) . A second set of MshB reactions of was first incubated 
with O.lrnM aGlcNAc-DNP before aGlcNAc-DNP was again added to the reactions 
at a final concentration of O.lmM. The reactions of the second set were stopped at 
183, 185, 190, 200, 215, 240, 300 and 360 minutes and analyzed (Figure 5.7, curve 
B). The regre sion curve of the two reaction sets are shown in Figure 5.7. 
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Figure 5.7: The two regre sion curves depicting the almost identical depletion of aGlcNAc-D P over 
time. urve A was obtained through enzymes reactions with fresh MshB and curve B with MshB 
incubated with aGlcNAc-DNP for 180 mins .. 
Results shown by the two regression curves are inconclusive. The two curves are 
nearly identical and in both cases most of the substrate has been depleted in the 180 
minute incubation period. This mean that free thiol of the rearrangement product 
does not inhibit MshB. However, at the 25 minute point in each of the two reactions 
there is almost a l OnM difference in substrate concentration in the two reaction 
mixtures, with the lower concentration in the fresh MshB reaction. This could mean 
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that the incubation of MshB with aGlcNAc-DNP for 180 minutes did have a small 
inhibitory effect on the enzyme. 
5.3 Mtr 
During this study Mtr was recombinantly expressed in E. coli for the first time 
(Chapter 2). This means that the enzyme was not produced in its native mycobacterial 
environment, it was not known if the enzyme would show the same activity as 
previously published (5). The activity of Mtr was tested in a steady-state kinetic assay 
with the synthetically prepared 2(N-acetyl-L-cysteiny l)-amino-2-deoxy-( a/~)-D­
glucopyranoside or des-myo-inositol mycothiol disulfide (DI-MSSM) (4.26) (Chapter 
4). 
5.3.1 FAD scan 
After Mtr was successfully expressed and purified on small scale, a fluorescent flavin 
adenine dinucleotide (FAD) scan was preformed. This was performed to verify that 
Mtr was expressed with bound FAD, which would give a good indication that the 
enzyme will show activity. An absorption maximum at 530nm was obtained which is 
consistent with the absorption maxima for FAD. 
5.3.2 Activity with Dl-MSSM 
The kinetic parameters for Mtr were determined in a NADPH assay and were found to 
have a Km = 504±109µM, Vmax = 0.0674±0.0043nmoles/s and kcat = 10.98±0.70s·1• 
The Km compares well with the previously published Km values for DI-MSSM with 
Mtr, 4lOµM and 510±40µM respectively (5, 6). The Michealis-Menten curve fit gave 
an R=0.9496 (P<0.001) and is given in Figure 5.8. 
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Figure 5.8: The steady late kinetics of Mtr with DI-M SM. Each point represents the average and the 
bars the standard error. The olid line repre ents the best-fit of the data to the Michaelis-Menten equation. 
5.4 Conclusion 
Jn the reactions with M hB and aGlcNAc-DNP it wa found that the N-deacetylation 
of the substrate happens twice as fast as the N-deacetylation of the natural substrate. It 
was also found that after the N-dcacetylation of aGlcNAc-DNP, the dinitrophenyl 
moiety migrates from the sulfur to the free amine in an intrarnolecular S--+N Smiles 
rearrangement. This is the first evidence of this type of reaction mediated by an 
enzyme. The formation of the rearrangement product was proven by a DTNB 
derivatization of the free thiol. NMR and mass spectroscopic studies are currently 
underway to conclusively prove the formation of the free thiol product. 
The result obtained from the activity of Mtr with DI-MSSM shows that the Mtr 
expressed in E. coli is indeed active, with a Km similar to the one previously published 
for DI-MSSM. 
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5.5 Experimental 
5.5.J Enzyme reactions 
5.5.1.l MshB reactions 
The MshB reactions were performed as published by Newton et al., 2006 (2). All the 
reactions performed in preparation for LCMS and HLPC analysis was accomplished 
in a final volume of 250µ1. The reaction mixture consisted of 1.3µ1 19.2mM 
aGlcNAc-DNP substrate stock solution (final concentration of O.lmM), 4.7µ1 
4.3mg/ml MshB stock (final concentration of l.5µg/µl) and 244µ1 reaction buffer 
(50mM l-IEPES, 50rnM NaCl, pH 7.4). At the specific time points the enzyme 
reactions were topped by denaturing the enzyme at 95°C for 5min, after which the 
denatured enzyme was pelleted through centrifugation for 5min. The reaction 
mixtures were transferred to LCMS or HPLC vials and analyzed. 
5.5.2 LCMS analysis 
The same LCMS method used in the quantitation of the mycothiol pathway 
intermediates ( hapter 3, section 3.4.4) was used in the analysis of the MshB 
dcacetylation of a-GlcNAc-DNP. 
Samples were analyzed on an ACQUITY UPLC sy tern (Waters Corp.) with an 
autosampler and a Synergy 4 µM Fusion RP, 250x2rnm column (Phenomenex). The 
sample injection volume was 20µ1 and the autosampler syringe was washed with 
solvent A (0.1 % [ormic acid in water) before each injection. A gradient elution 
program with a flow-rate of 0.20 ml/min was used for the analysis. The gradient was 
as follows: 100% solvent A for 8 min; 7 min linear increase up to 95% solvent B 
(0.1 % formic acid in acetonitrile); 95% B step for 3 min; 95% solvent A from 18 to 
20 min. The total analysi time wa 20 min. 
Detection was performed on a QTOF Ultima API quadrupole mass spectrometer 
(Micromass, Manchester, UK). Analyte were detected in the positive ion mode. The 
capillary voltage was set at 3500 V. The source temperature and the nebulization gas 
temperature were set at 120 °C and 400 °C, respectively. The cone voltages were set at 
35V. Data was processed using MassLynx™ software (Micromass, Manchester, UK). 
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5.5.3 HPLC analysis 
The enzyme reactions were analyzed on a Synergy 4 µM Fusion RP, 250x2mm 
column (Phenomenex) on an Agilent 1100 Series HPLC with an autosampler and 
diode array detector. An isocratic program of 30% MeOH/H20 was used at a flow rate 
of 0.350ml/min. The total analysis time was lOmin. Elution of the substrate was 
monitored at 330nm. Data was processed with ChemStation for LC 3D software. 
5.5.4 Spectrophotometric analysis 
5.5.4.l DNTBassay 
MshB reaction with aGlcNAc-DNP were set up, incubated and stopped as described 
in ection 5.5.1.1. The reaction mixtures were transferred to clean tubes and DNTB 
added to a final concentration of 0.lmM. The reactions were incubated at room 
temperature for 5 minutes after which it was transferred to a UV Corning 96 well 
plate. Absorption was measured at 412nm with the Thermo Varioskan™. 
5.5.4.2 FAD cans 
The fluorescent can for FAD in the purified Mtr enzyme wa performed with the 
Thermo Varioskan™. Black Corning 96-well microtitre plate were u ed for the 
fluorescent cans. The excitation wavelength was 370nm, which wa scanned over an 
emissions wavelength range of 420-680nm with a 5nm step size. The excitation was 
measured at a wavelength of 512nm. 
5.5.4.3 Mir activity assay 
The Mtr enzyme activity a ay was performed in an UV Corning 96 well plate. The 
reaction was monitored through the oxidation of P-NADPH to P-NADP+ at 340nm. 
The Dl-MS M concentration range wa setup in the 96-well plate. The concentrations 
of Dl-M M used were OµM, 75µM, 200µM, 800µM, 1200µM, 2500µM and 
5000µM. The enzyme reaction were initiated with the addition of the reaction 
mixture to the Dl-MSSM concentration. The reaction mixture contained 50mM 
HEPES, 0. lmM EDTA, lOOµM P-NADPH and 20nM Mtr, at pH 7.6. 
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5.5.5 Statistical Data Analysis 
Sigma Plot version 9.01 (SyStat Software, Inc.) was used for all data analysis and the 
visualization of the data. 
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6.1 Enzyme expression 
MshB and Mtr was successfully expressed and purified during this study. The 
expression and purification of MshB was perfonned more efficiently, thus producing 
a higher expre ion yield than previously described (I). Also, Mtr was recombinantly 
expressed and purified from E. coli for the first time during this study. Through 
collaborative work, determination of the crystal structure of Mtr is under progress. If 
successful, this accomplishment would contribute a major step forward in the 
structure-based development of inhibitors and substrate analogues for Mtr. 
The methods development for the oluble expre ion of Mtr may now be used in 
conjunction with ite-directed mutagene i tudie for the expres ion of different 
mutant forms of the Mtr enzymes. This would be a u eful tool in further studies with 
Mtr, e pecially studies involving the binding modes of different moietie . 
6.2 Quantitation of mycothiol and pathway intermediates 
We successfully developed a new 1-IPLC- ~ Sl/MS(TOF) method for the detection and 
quantitation of MSII and its pathway intermediates. Thi method wa u ed for the 
imultaneous detection of MSH, MSSM, and aGlcN-lns in M smegmatis cell lysates. 
Unlike previous IIPLC-UV detection methods, there is no need for the derivatisation 
of the analytes and all three analytes could be detected in a single injection of the M 
smegmatis cell ly ate. Furthermore, the method was also used to track the fluctuating 
MSH:MSSM level in M smegmatis cells growing under oxidative stress conditions. 
Future work will focu on the determination of optimised calibration curve and on 
the reproducibility of the measurements of the different analytes. This would be 
important in the accurate determination of the amount of MSH present in M 
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smegmatis cells and other actinomycetes, because preliminary results reported during 
this study would suggest that there was a large underestimation of cellular MSH levels 
in previous studies (2, 3). 
The biggest advantage of this method is that the MSH biosynthetic enzymes, as well 
as related enzymes that utilize mycothiol, can now be studied in various physiological 
conditions. The effect of prospective drugs or inhibitors on these enzymes in either 
free or whole cell assays can now be monitored with greater ease. Thus, the 
development of a multi well-based form of this method would be crucial to allow the 
high-throughput analysis of new or existing compounds. With our current 
methodology, the extrapolation of this method to a high-throughput 96-well plate 
format would be trivial. 
6.3 Synthesis of substrate analogues 
The Mtr substrate analogue, des-myo-inositol mycothiol disulfide (DI-MSSM), was 
synthesized by an improved method compared to the previous published synthesis ( 4) . 
This substrate analogue, rather than MSSM, was u ed to test the activity of the 
recombinantly expressed Mtr. The advantage of using DI-MSSM is that it is less 
expensive and time-con urning to synthesize than MSSM. lt can also be used as an 
alternative I igand in the determination of the crysta l structure coordinates of Mtr. 
During this study we al o synthesized a range of substrate analogues for MshB. The 
synthesized thioglycoside disaccharides would serve as new scaffolds for the 
development of a new range of potential inhibitors against MshB and Mtr (with 
further development). We al o succe sfully synthesized a series of fluorogenic 
thioglycosides. These analogues will serve a vital function in the development of new 
assay method for inhibitor creening not only for MshB, but al o for Mea and Mtr. 
The molecules de igned against MshB can easily be transformed into substrate 
analogues for the other MSH-utilising enzymes (like Mtr) through simple synthetic 
methods. Future design of sub trate analogues for Mtr will also exploit fluorescence 
resonance energy transfer (FRET) based strategies. These types of molecules will 
serve as competitive substrates in competitive-binding assays, where the loss of 
emission from the acceptor moiety would be an indication of how well the target 
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molecule binds to the Mtr active site (Figure 6.1 ). The biggest challenge in 
synthesizing these FRET based molecules would be to bring the donor and acceptor 
fluorophore moieties within an appropriate Forster distance form each other, ensuring 
that energy transfer would take place upon irradiation of the donor moiety. 
Donor 
Donor 
0 
NH ~ 1( 
~ 0 ;: 
H 
hv' Mu-
HO 
OH 
Acceptor 
f· Rl· l 
Figu re 6.1: Hypothetical FRET based molecu le to be u ed in Mtr assays. 
6.4 Enzymology 
The DI-MS M ub trate analogue was tested in a NADPH-dependent a ay with Mtr. 
Nearly identical kinetic parameter to that previously reported were obtained (5). This 
concluded the first succes ful expression and purification of Mtr u ing E. coli as 
expression host. 
urthermore, aGlcNAc-DNP wa u ed as ub trate analogue in assays with MshB. 
LCM analysi proved that aGlcNAc-DNP i converted to aGlcN-DNP through the 
action of MshB. Through a time dependent progression curve analy i of the MshB 
deacetylation reaction with aGlcNAc-DNP it was ob erved that MshB i almost twice 
as reactive with aGlcNAc-DNP compared to its natural substrate. Determination of 
the full kinetic parameters is currently underway to confirm these preliminary results. 
ither way, the e results proved a very exciting prospect for the further development 
of the fir t photometric assay for MshB. 
During the MshB-mediated N-deacetylation of aGlcNAc-DNP it wa also discovered 
that the aGJcN-DNP product undergoes a s-N intramolecular rearrangement, 
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producing the free thiol product. This is the first evidence of an enzyme-mediated 
rearrangement of this type and could be exploited in the further development of 
inhibitors. Studies are currently underway to conclusively confirm the formation and 
detailed kinetics and the structure of the rearrangement product. 
6.5 Final Remarks 
The mycothiol pathway and related enzymes had been the focus of numerous studies. 
From these studies it was proven that the pathway and related mechanisms provide 
ample targets for the design of new drugs against M tuberculosis. Active research is 
currently being conducted to provide lead compounds against these targets. One of the 
major reasons why this process is not proceeding faster is the current screening 
methods employed to evaluate compound libraries. During this study we have laid the 
foundation for the development of new analytical and screening methods, which 
would streamline the drug discovery process that target these enzymes and the 
mycothiol pathway. 
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